id	sid	tid	token	lemma	pos
ajird-1300	1	1	american	american	PROPN
ajird-1300	1	2	journal	journal	PROPN
ajird-1300	1	3	of	of	ADP
ajird-1300	1	4	interdisciplinary	interdisciplinary	ADJ
ajird-1300	1	5	research	research	NOUN
ajird-1300	1	6	and	and	CCONJ
ajird-1300	1	7	development	development	NOUN
ajird-1300	1	8	issn	issn	PROPN
ajird-1300	1	9	online	online	NOUN
ajird-1300	1	10	:	:	PUNCT
ajird-1300	1	11	2771	2771	NUM
ajird-1300	1	12	-	-	SYM
ajird-1300	1	13	8948	8948	NUM
ajird-1300	1	14	website	website	NOUN
ajird-1300	1	15	:	:	PUNCT
ajird-1300	1	16	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-1300	1	17	volume	volume	NOUN
ajird-1300	1	18	33	33	NUM
ajird-1300	1	19	,	,	PUNCT
ajird-1300	1	20	october	october	PROPN
ajird-1300	1	21	2024	2024	NUM
ajird-1300	1	22	6	6	NUM
ajird-1300	1	23	|	|	ADV
ajird-1300	1	24	p	p	X
ajird-1300	1	25	a	a	DET
ajird-1300	1	26	g	g	NOUN
ajird-1300	1	27	e	e	NOUN
ajird-1300	1	28	metabolic	metabolic	NOUN
ajird-1300	1	29	complications	complication	NOUN
ajird-1300	1	30	of	of	ADP
ajird-1300	1	31	growth	growth	NOUN
ajird-1300	1	32	hormone	hormone	NOUN
ajird-1300	1	33	deficiency	deficiency	NOUN
ajird-1300	1	34	in	in	ADP
ajird-1300	1	35	patients	patient	NOUN
ajird-1300	1	36	with	with	ADP
ajird-1300	1	37	ischemic	ischemic	ADJ
ajird-1300	1	38	heart	heart	NOUN
ajird-1300	1	39	disease	disease	NOUN
ajird-1300	1	40	urmanova	urmanova	ADJ
ajird-1300	1	41	yulduz	yulduz	PROPN
ajird-1300	1	42	makhkamovna	makhkamovna	VERB
ajird-1300	1	43	doctor	doctor	NOUN
ajird-1300	1	44	of	of	ADP
ajird-1300	1	45	medical	medical	ADJ
ajird-1300	1	46	sciences	science	NOUN
ajird-1300	1	47	,	,	PUNCT
ajird-1300	1	48	professor	professor	NOUN
ajird-1300	1	49	of	of	ADP
ajird-1300	1	50	the	the	DET
ajird-1300	1	51	department	department	NOUN
ajird-1300	1	52	of	of	ADP
ajird-1300	1	53	clinical	clinical	ADJ
ajird-1300	1	54	disciplines	discipline	NOUN
ajird-1300	1	55	,	,	PUNCT
ajird-1300	1	56	alfraganus	alfraganus	NOUN
ajird-1300	1	57	university	university	NOUN
ajird-1300	1	58	office	office	NOUN
ajird-1300	1	59	address	address	NOUN
ajird-1300	1	60	:	:	PUNCT
ajird-1300	1	61	tashkent	tashkent	ADJ
ajird-1300	1	62	,	,	PUNCT
ajird-1300	1	63	100190	100190	NUM
ajird-1300	1	64	,	,	PUNCT
ajird-1300	1	65	yukori	yukori	PROPN
ajird-1300	1	66	karakamysh	karakamysh	PROPN
ajird-1300	1	67	street	street	PROPN
ajird-1300	1	68	2	2	NUM
ajird-1300	1	69	a	a	DET
ajird-1300	1	70	tel	tel	NOUN
ajird-1300	1	71	mob	mob	NOUN
ajird-1300	1	72	+99890	+99890	NUM
ajird-1300	1	73	-	-	SYM
ajird-1300	1	74	9040165	9040165	NUM
ajird-1300	1	75	,	,	PUNCT
ajird-1300	1	76	email	email	NOUN
ajird-1300	1	77	yulduz.urmanova@mail.ru	yulduz.urmanova@mail.ru	VERB
ajird-1300	1	78	abstract	abstract	ADV
ajird-1300	1	79	in	in	ADP
ajird-1300	1	80	this	this	DET
ajird-1300	1	81	article	article	NOUN
ajird-1300	1	82	,	,	PUNCT
ajird-1300	1	83	the	the	DET
ajird-1300	1	84	authors	author	NOUN
ajird-1300	1	85	discussed	discuss	VERB
ajird-1300	1	86	the	the	DET
ajird-1300	1	87	results	result	NOUN
ajird-1300	1	88	of	of	ADP
ajird-1300	1	89	investigation	investigation	NOUN
ajird-1300	1	90	of	of	ADP
ajird-1300	1	91	21	21	NUM
ajird-1300	1	92	adults	adult	NOUN
ajird-1300	1	93	with	with	ADP
ajird-1300	1	94	ischemic	ischemic	ADJ
ajird-1300	1	95	heart	heart	NOUN
ajird-1300	1	96	disease	disease	NOUN
ajird-1300	1	97	(	(	PUNCT
ajird-1300	1	98	ihd	ihd	ADJ
ajird-1300	1	99	)	)	PUNCT
ajird-1300	1	100	and	and	CCONJ
ajird-1300	1	101	metabolic	metabolic	NOUN
ajird-1300	1	102	syndrome	syndrome	NOUN
ajird-1300	1	103	with	with	ADP
ajird-1300	1	104	growth	growth	NOUN
ajird-1300	1	105	hormone	hormone	NOUN
ajird-1300	1	106	deficiency	deficiency	NOUN
ajird-1300	1	107	syndrome	syndrome	NOUN
ajird-1300	1	108	in	in	ADP
ajird-1300	1	109	adults	adult	NOUN
ajird-1300	1	110	(	(	PUNCT
ajird-1300	1	111	ghd	ghd	NOUN
ajird-1300	1	112	)	)	PUNCT
ajird-1300	1	113	.	.	PUNCT
ajird-1300	2	1	the	the	DET
ajird-1300	2	2	investigation	investigation	NOUN
ajird-1300	2	3	of	of	ADP
ajird-1300	2	4	hormonal	hormonal	ADJ
ajird-1300	2	5	status	status	NOUN
ajird-1300	2	6	disorders	disorder	NOUN
ajird-1300	2	7	found	find	VERB
ajird-1300	2	8	of	of	ADP
ajird-1300	2	9	the	the	DET
ajird-1300	2	10	level	level	NOUN
ajird-1300	2	11	of	of	ADP
ajird-1300	2	12	sth	sth	NOUN
ajird-1300	2	13	and	and	CCONJ
ajird-1300	2	14	igf-1	igf-1	NOUN
ajird-1300	2	15	in	in	ADP
ajird-1300	2	16	blood	blood	NOUN
ajird-1300	2	17	plasma	plasma	NOUN
ajird-1300	2	18	.	.	PUNCT
ajird-1300	3	1	it	it	PRON
ajird-1300	3	2	was	be	AUX
ajird-1300	3	3	established	establish	VERB
ajird-1300	3	4	that	that	DET
ajird-1300	3	5	frequency	frequency	NOUN
ajird-1300	3	6	of	of	ADP
ajird-1300	3	7	ghd	ghd	NOUN
ajird-1300	3	8	in	in	ADP
ajird-1300	3	9	patients	patient	NOUN
ajird-1300	3	10	with	with	ADP
ajird-1300	3	11	ihd	ihd	NOUN
ajird-1300	3	12	of	of	ADP
ajird-1300	3	13	both	both	DET
ajird-1300	3	14	groups	group	NOUN
ajird-1300	3	15	was	be	AUX
ajird-1300	3	16	15	15	NUM
ajird-1300	3	17	cases	case	NOUN
ajird-1300	3	18	from	from	ADP
ajird-1300	3	19	21	21	NUM
ajird-1300	3	20	patients	patient	NOUN
ajird-1300	3	21	(	(	PUNCT
ajird-1300	3	22	71.4	71.4	NUM
ajird-1300	3	23	%	%	NOUN
ajird-1300	3	24	)	)	PUNCT
ajird-1300	3	25	.	.	PUNCT
ajird-1300	4	1	besides	besides	SCONJ
ajird-1300	4	2	that	that	PRON
ajird-1300	4	3	,	,	PUNCT
ajird-1300	4	4	8	8	NUM
ajird-1300	4	5	patients	patient	NOUN
ajird-1300	4	6	from	from	ADP
ajird-1300	4	7	15	15	NUM
ajird-1300	4	8	(	(	PUNCT
ajird-1300	4	9	53.3	53.3	NUM
ajird-1300	4	10	%	%	NOUN
ajird-1300	4	11	)	)	PUNCT
ajird-1300	4	12	with	with	ADP
ajird-1300	4	13	ghd	ghd	NOUN
ajird-1300	4	14	have	have	VERB
ajird-1300	4	15	low	low	ADJ
ajird-1300	4	16	levels	level	NOUN
ajird-1300	4	17	of	of	ADP
ajird-1300	4	18	gf-1	gf-1	ADV
ajird-1300	4	19	too	too	ADV
ajird-1300	4	20	.	.	PUNCT
ajird-1300	5	1	the	the	DET
ajird-1300	5	2	levels	level	NOUN
ajird-1300	5	3	of	of	ADP
ajird-1300	5	4	sth	sth	PROPN
ajird-1300	5	5	was	be	AUX
ajird-1300	5	6	in	in	ADP
ajird-1300	5	7	range	range	NOUN
ajird-1300	5	8	from	from	ADP
ajird-1300	5	9	0.15	0.15	NUM
ajird-1300	5	10	ng	ng	PROPN
ajird-1300	5	11	/	/	SYM
ajird-1300	5	12	ml	ml	NOUN
ajird-1300	5	13	to	to	ADP
ajird-1300	5	14	0.53	0.53	NUM
ajird-1300	5	15	ng	ng	PROPN
ajird-1300	5	16	/	/	SYM
ajird-1300	5	17	ml	ml	NOUN
ajird-1300	5	18	in	in	ADP
ajird-1300	5	19	13	13	NUM
ajird-1300	5	20	(	(	PUNCT
ajird-1300	5	21	86.6	86.6	NUM
ajird-1300	5	22	%	%	NOUN
ajird-1300	5	23	)	)	PUNCT
ajird-1300	5	24	patients	patient	NOUN
ajird-1300	5	25	from	from	ADP
ajird-1300	5	26	15	15	NUM
ajird-1300	5	27	,	,	PUNCT
ajird-1300	5	28	which	which	PRON
ajird-1300	5	29	noted	note	VERB
ajird-1300	5	30	the	the	DET
ajird-1300	5	31	high	high	ADJ
ajird-1300	5	32	frequency	frequency	NOUN
ajird-1300	5	33	of	of	ADP
ajird-1300	5	34	low	low	ADJ
ajird-1300	5	35	levels	level	NOUN
ajird-1300	5	36	of	of	ADP
ajird-1300	5	37	sth	sth	NOUN
ajird-1300	5	38	in	in	ADP
ajird-1300	5	39	both	both	DET
ajird-1300	5	40	groups	group	NOUN
ajird-1300	5	41	.	.	PUNCT
ajird-1300	6	1	and	and	CCONJ
ajird-1300	6	2	the	the	DET
ajird-1300	6	3	levels	level	NOUN
ajird-1300	6	4	of	of	ADP
ajird-1300	6	5	igf-1	igf-1	NOUN
ajird-1300	6	6	in	in	ADP
ajird-1300	6	7	range	range	NOUN
ajird-1300	6	8	rom	rom	PROPN
ajird-1300	6	9	58	58	NUM
ajird-1300	6	10	ng	ng	NOUN
ajird-1300	6	11	/	/	SYM
ajird-1300	6	12	ml	ml	NOUN
ajird-1300	6	13	to	to	ADP
ajird-1300	6	14	120	120	NUM
ajird-1300	6	15	ng	ng	NOUN
ajird-1300	6	16	/	/	SYM
ajird-1300	6	17	ml	ml	NOUN
ajird-1300	6	18	in	in	ADP
ajird-1300	6	19	10	10	NUM
ajird-1300	6	20	(	(	PUNCT
ajird-1300	6	21	50	50	NUM
ajird-1300	6	22	%	%	NOUN
ajird-1300	6	23	)	)	PUNCT
ajird-1300	6	24	from	from	ADP
ajird-1300	6	25	20	20	NUM
ajird-1300	6	26	patients	patient	NOUN
ajird-1300	6	27	.	.	PUNCT
ajird-1300	7	1	keywords	keyword	NOUN
ajird-1300	7	2	:	:	PUNCT
ajird-1300	7	3	adult	adult	NOUN
ajird-1300	7	4	growth	growth	NOUN
ajird-1300	7	5	hormone	hormone	NOUN
ajird-1300	7	6	deficiency	deficiency	NOUN
ajird-1300	7	7	(	(	PUNCT
ajird-1300	7	8	aghd	aghd	PROPN
ajird-1300	7	9	)	)	PUNCT
ajird-1300	7	10	,	,	PUNCT
ajird-1300	7	11	coronary	coronary	ADJ
ajird-1300	7	12	heart	heart	NOUN
ajird-1300	7	13	disease	disease	NOUN
ajird-1300	7	14	(	(	PUNCT
ajird-1300	7	15	chd	chd	NOUN
ajird-1300	7	16	)	)	PUNCT
ajird-1300	7	17	,	,	PUNCT
ajird-1300	7	18	metabolic	metabolic	NOUN
ajird-1300	7	19	syndrome	syndrome	NOUN
ajird-1300	7	20	(	(	PUNCT
ajird-1300	7	21	ms	ms	NOUN
ajird-1300	7	22	)	)	PUNCT
ajird-1300	7	23	introduction	introduction	NOUN
ajird-1300	7	24	one	one	NUM
ajird-1300	7	25	of	of	ADP
ajird-1300	7	26	the	the	DET
ajird-1300	7	27	first	first	ADJ
ajird-1300	7	28	authors	author	NOUN
ajird-1300	7	29	to	to	PART
ajird-1300	7	30	publish	publish	VERB
ajird-1300	7	31	for	for	ADP
ajird-1300	7	32	the	the	DET
ajird-1300	7	33	first	first	ADJ
ajird-1300	7	34	timemore	timemore	NOUN
ajird-1300	7	35	than	than	ADP
ajird-1300	7	36	25	25	NUM
ajird-1300	7	37	years	year	NOUN
ajird-1300	7	38	ago	ago	ADV
ajird-1300	7	39	,	,	PUNCT
ajird-1300	7	40	research	research	NOUN
ajird-1300	7	41	onadult	onadult	NOUN
ajird-1300	7	42	growth	growth	NOUN
ajird-1300	7	43	hormone	hormone	NOUN
ajird-1300	7	44	deficiency	deficiency	NOUN
ajird-1300	7	45	(	(	PUNCT
ajird-1300	7	46	the	the	DET
ajird-1300	7	47	first	first	ADJ
ajird-1300	7	48	person	person	NOUN
ajird-1300	7	49	to	to	PART
ajird-1300	7	50	study	study	VERB
ajird-1300	7	51	the	the	DET
ajird-1300	7	52	dhrv	dhrv	PROPN
ajird-1300	7	53	problem	problem	NOUN
ajird-1300	7	54	was	be	AUX
ajird-1300	7	55	professor	professor	NOUN
ajird-1300	7	56	a.b	a.b	PROPN
ajird-1300	7	57	.	.	PROPN
ajird-1300	7	58	grossman	grossman	PROPN
ajird-1300	7	59	with	with	ADP
ajird-1300	7	60	his	his	PRON
ajird-1300	7	61	work	work	NOUN
ajird-1300	7	62	on	on	ADP
ajird-1300	7	63	the	the	DET
ajird-1300	7	64	effect	effect	NOUN
ajird-1300	7	65	of	of	ADP
ajird-1300	7	66	radiation	radiation	NOUN
ajird-1300	7	67	therapy	therapy	NOUN
ajird-1300	7	68	on	on	ADP
ajird-1300	7	69	pituitary	pituitary	ADJ
ajird-1300	7	70	tumors	tumor	NOUN
ajird-1300	7	71	,	,	PUNCT
ajird-1300	7	72	and	and	CCONJ
ajird-1300	7	73	he	he	PRON
ajird-1300	7	74	noted	note	VERB
ajird-1300	7	75	that	that	SCONJ
ajird-1300	7	76	the	the	DET
ajird-1300	7	77	only	only	ADJ
ajird-1300	7	78	early	early	ADJ
ajird-1300	7	79	-	-	PUNCT
ajird-1300	7	80	onset	onset	NOUN
ajird-1300	7	81	endocrinopathy	endocrinopathy	ADJ
ajird-1300	7	82	was	be	AUX
ajird-1300	7	83	a	a	DET
ajird-1300	7	84	deficiency	deficiency	NOUN
ajird-1300	7	85	of	of	ADP
ajird-1300	7	86	growth	growth	NOUN
ajird-1300	7	87	hormone	hormone	NOUN
ajird-1300	7	88	:	:	PUNCT
ajird-1300	7	89	“	"	PUNCT
ajird-1300	7	90	i	i	PRON
ajird-1300	7	91	did	do	AUX
ajird-1300	7	92	not	not	PART
ajird-1300	7	93	attach	attach	VERB
ajird-1300	7	94	much	much	ADJ
ajird-1300	7	95	importance	importance	NOUN
ajird-1300	7	96	to	to	ADP
ajird-1300	7	97	this	this	PRON
ajird-1300	7	98	because	because	SCONJ
ajird-1300	7	99	“	"	PUNCT
ajird-1300	7	100	it	it	PRON
ajird-1300	7	101	had	have	VERB
ajird-1300	7	102	no	no	DET
ajird-1300	7	103	clinical	clinical	ADJ
ajird-1300	7	104	significance	significance	NOUN
ajird-1300	7	105	,	,	PUNCT
ajird-1300	7	106	since	since	SCONJ
ajird-1300	7	107	the	the	DET
ajird-1300	7	108	patients	patient	NOUN
ajird-1300	7	109	were	be	AUX
ajird-1300	7	110	adults	adult	NOUN
ajird-1300	7	111	”	"	PUNCT
ajird-1300	8	1	[	[	X
ajird-1300	8	2	7	7	NUM
ajird-1300	8	3	]	]	PUNCT
ajird-1300	8	4	.	.	PUNCT
ajird-1300	9	1	at	at	ADP
ajird-1300	9	2	present	present	ADJ
ajird-1300	9	3	,	,	PUNCT
ajird-1300	9	4	the	the	DET
ajird-1300	9	5	problem	problem	NOUN
ajird-1300	9	6	of	of	ADP
ajird-1300	9	7	dhrv	dhrv	PROPN
ajird-1300	9	8	is	be	AUX
ajird-1300	9	9	the	the	DET
ajird-1300	9	10	subject	subject	NOUN
ajird-1300	9	11	of	of	ADP
ajird-1300	9	12	many	many	ADJ
ajird-1300	9	13	studies	study	NOUN
ajird-1300	9	14	by	by	ADP
ajird-1300	9	15	russian	russian	ADJ
ajird-1300	9	16	and	and	CCONJ
ajird-1300	9	17	foreign	foreign	ADJ
ajird-1300	9	18	authors	author	NOUN
ajird-1300	9	19	.	.	PUNCT
ajird-1300	10	1	thus	thus	ADV
ajird-1300	10	2	,	,	PUNCT
ajird-1300	10	3	the	the	DET
ajird-1300	10	4	role	role	NOUN
ajird-1300	10	5	of	of	ADP
ajird-1300	10	6	growth	growth	NOUN
ajird-1300	10	7	hormone	hormone	NOUN
ajird-1300	10	8	deficiency	deficiency	NOUN
ajird-1300	10	9	in	in	ADP
ajird-1300	10	10	the	the	DET
ajird-1300	10	11	development	development	NOUN
ajird-1300	10	12	of	of	ADP
ajird-1300	10	13	coronary	coronary	ADJ
ajird-1300	10	14	heart	heart	NOUN
ajird-1300	10	15	disease	disease	NOUN
ajird-1300	10	16	in	in	ADP
ajird-1300	10	17	patients	patient	NOUN
ajird-1300	10	18	with	with	ADP
ajird-1300	10	19	type	type	NOUN
ajird-1300	10	20	2	2	NUM
ajird-1300	10	21	diabetes	diabetes	NOUN
ajird-1300	10	22	mellitus	mellitus	NOUN
ajird-1300	10	23	(	(	PUNCT
ajird-1300	10	24	dm	dm	PROPN
ajird-1300	10	25	)	)	PUNCT
ajird-1300	10	26	was	be	AUX
ajird-1300	10	27	shown	show	VERB
ajird-1300	10	28	in	in	ADP
ajird-1300	10	29	the	the	DET
ajird-1300	10	30	work	work	NOUN
ajird-1300	10	31	of	of	ADP
ajird-1300	10	32	v.n	v.n	PROPN
ajird-1300	10	33	.	.	PROPN
ajird-1300	10	34	shchukina	shchukina	PROPN
ajird-1300	10	35	,	,	PUNCT
ajird-1300	10	36	2006	2006	NUM
ajird-1300	10	37	[	[	X
ajird-1300	10	38	3	3	NUM
ajird-1300	10	39	]	]	PUNCT
ajird-1300	10	40	,	,	PUNCT
ajird-1300	10	41	which	which	PRON
ajird-1300	10	42	showed	show	VERB
ajird-1300	10	43	that	that	SCONJ
ajird-1300	10	44	the	the	DET
ajird-1300	10	45	nature	nature	NOUN
ajird-1300	10	46	of	of	ADP
ajird-1300	10	47	the	the	DET
ajird-1300	10	48	course	course	NOUN
ajird-1300	10	49	of	of	ADP
ajird-1300	10	50	coronary	coronary	ADJ
ajird-1300	10	51	heart	heart	NOUN
ajird-1300	10	52	disease	disease	NOUN
ajird-1300	10	53	and	and	CCONJ
ajird-1300	10	54	its	its	PRON
ajird-1300	10	55	progression	progression	NOUN
ajird-1300	10	56	in	in	ADP
ajird-1300	10	57	patients	patient	NOUN
ajird-1300	10	58	with	with	ADP
ajird-1300	10	59	type	type	NOUN
ajird-1300	10	60	2	2	NUM
ajird-1300	10	61	dm	dm	NOUN
ajird-1300	10	62	are	be	AUX
ajird-1300	10	63	associated	associate	VERB
ajird-1300	10	64	with	with	ADP
ajird-1300	10	65	insufficient	insufficient	ADJ
ajird-1300	10	66	secretion	secretion	NOUN
ajird-1300	10	67	of	of	ADP
ajird-1300	10	68	growth	growth	NOUN
ajird-1300	10	69	hormone	hormone	NOUN
ajird-1300	10	70	.	.	PUNCT
ajird-1300	11	1	she	she	PRON
ajird-1300	11	2	notes	note	VERB
ajird-1300	11	3	that	that	SCONJ
ajird-1300	11	4	ghrd	ghrd	PROPN
ajird-1300	11	5	plays	play	VERB
ajird-1300	11	6	a	a	DET
ajird-1300	11	7	leading	lead	VERB
ajird-1300	11	8	role	role	NOUN
ajird-1300	11	9	in	in	ADP
ajird-1300	11	10	the	the	DET
ajird-1300	11	11	development	development	NOUN
ajird-1300	11	12	of	of	ADP
ajird-1300	11	13	dyslipoproteinemia	dyslipoproteinemia	NOUN
ajird-1300	11	14	,	,	PUNCT
ajird-1300	11	15	which	which	PRON
ajird-1300	11	16	underlies	underlie	VERB
ajird-1300	11	17	atherosclerosis	atherosclerosis	NOUN
ajird-1300	11	18	,	,	PUNCT
ajird-1300	11	19	and	and	CCONJ
ajird-1300	11	20	the	the	DET
ajird-1300	11	21	development	development	NOUN
ajird-1300	11	22	and	and	CCONJ
ajird-1300	11	23	progression	progression	NOUN
ajird-1300	11	24	of	of	ADP
ajird-1300	11	25	“	"	PUNCT
ajird-1300	11	26	late	late	ADJ
ajird-1300	11	27	”	"	PUNCT
ajird-1300	11	28	microand	microand	NOUN
ajird-1300	11	29	macrovascular	macrovascular	ADJ
ajird-1300	11	30	complications	complication	NOUN
ajird-1300	11	31	of	of	ADP
ajird-1300	11	32	diabetes	diabetes	NOUN
ajird-1300	11	33	,	,	PUNCT
ajird-1300	11	34	decreased	decrease	VERB
ajird-1300	11	35	physical	physical	ADJ
ajird-1300	11	36	performance	performance	NOUN
ajird-1300	11	37	and	and	CCONJ
ajird-1300	11	38	changes	change	NOUN
ajird-1300	11	39	in	in	ADP
ajird-1300	11	40	intracardiac	intracardiac	ADJ
ajird-1300	11	41	hemodynamics	hemodynamic	NOUN
ajird-1300	11	42	.	.	PUNCT
ajird-1300	12	1	american	american	PROPN
ajird-1300	12	2	journal	journal	PROPN
ajird-1300	12	3	of	of	ADP
ajird-1300	12	4	interdisciplinary	interdisciplinary	ADJ
ajird-1300	12	5	research	research	NOUN
ajird-1300	12	6	and	and	CCONJ
ajird-1300	12	7	development	development	NOUN
ajird-1300	12	8	issn	issn	PROPN
ajird-1300	12	9	online	online	NOUN
ajird-1300	12	10	:	:	PUNCT
ajird-1300	12	11	2771	2771	NUM
ajird-1300	12	12	-	-	SYM
ajird-1300	12	13	8948	8948	NUM
ajird-1300	12	14	website	website	NOUN
ajird-1300	12	15	:	:	PUNCT
ajird-1300	12	16	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-1300	12	17	volume	volume	NOUN
ajird-1300	12	18	33	33	NUM
ajird-1300	12	19	,	,	PUNCT
ajird-1300	12	20	october	october	PROPN
ajird-1300	12	21	2024	2024	NUM
ajird-1300	12	22	7	7	NUM
ajird-1300	12	23	|	|	ADV
ajird-1300	12	24	p	p	X
ajird-1300	12	25	a	a	DET
ajird-1300	12	26	g	g	NOUN
ajird-1300	12	27	e	e	NOUN
ajird-1300	12	28	in	in	ADP
ajird-1300	12	29	patients	patient	NOUN
ajird-1300	12	30	with	with	ADP
ajird-1300	12	31	adult	adult	NOUN
ajird-1300	12	32	growth	growth	NOUN
ajird-1300	12	33	hormone	hormone	NOUN
ajird-1300	12	34	deficiency	deficiency	NOUN
ajird-1300	12	35	syndrome	syndrome	NOUN
ajird-1300	12	36	(	(	PUNCT
ajird-1300	12	37	aghd)there	aghd)there	X
ajird-1300	12	38	are	be	AUX
ajird-1300	12	39	several	several	ADJ
ajird-1300	12	40	metabolic	metabolic	NOUN
ajird-1300	12	41	abnormalities	abnormality	NOUN
ajird-1300	12	42	and	and	CCONJ
ajird-1300	12	43	it	it	PRON
ajird-1300	12	44	has	have	AUX
ajird-1300	12	45	been	be	AUX
ajird-1300	12	46	found	find	VERB
ajird-1300	12	47	that	that	SCONJ
ajird-1300	12	48	there	there	PRON
ajird-1300	12	49	is	be	VERB
ajird-1300	12	50	increased	increase	VERB
ajird-1300	12	51	cardiovascular	cardiovascular	ADJ
ajird-1300	12	52	morbidity	morbidity	NOUN
ajird-1300	12	53	and	and	CCONJ
ajird-1300	12	54	mortality	mortality	NOUN
ajird-1300	12	55	in	in	ADP
ajird-1300	12	56	patients	patient	NOUN
ajird-1300	12	57	with	with	ADP
ajird-1300	12	58	ghd	ghd	NOUN
ajird-1300	12	59	with	with	ADP
ajird-1300	12	60	hypopituitarism	hypopituitarism	NOUN
ajird-1300	13	1	[	[	X
ajird-1300	13	2	1	1	NUM
ajird-1300	13	3	-	-	SYM
ajird-1300	13	4	3	3	NUM
ajird-1300	13	5	]	]	PUNCT
ajird-1300	13	6	may	may	AUX
ajird-1300	13	7	be	be	AUX
ajird-1300	13	8	related	relate	VERB
ajird-1300	13	9	to	to	ADP
ajird-1300	13	10	missing	miss	VERB
ajird-1300	13	11	metabolic	metabolic	NOUN
ajird-1300	13	12	effects	effect	NOUN
ajird-1300	13	13	of	of	ADP
ajird-1300	13	14	gh	gh	PROPN
ajird-1300	13	15	.	.	PROPN
ajird-1300	13	16	johannsson	johannsson	PROPN
ajird-1300	13	17	and	and	CCONJ
ajird-1300	13	18	bengtsson	bengtsson	NOUN
ajird-1300	14	1	[	[	X
ajird-1300	14	2	8,9	8,9	NUM
ajird-1300	14	3	]	]	PUNCT
ajird-1300	14	4	indicated	indicate	VERB
ajird-1300	14	5	that	that	SCONJ
ajird-1300	14	6	the	the	DET
ajird-1300	14	7	adult	adult	NOUN
ajird-1300	14	8	phenotype	phenotype	NOUN
ajird-1300	14	9	of	of	ADP
ajird-1300	14	10	dhrv	dhrv	ADJ
ajird-1300	14	11	shares	share	NOUN
ajird-1300	14	12	features	feature	VERB
ajird-1300	14	13	with	with	ADP
ajird-1300	14	14	metabolic	metabolic	NOUN
ajird-1300	14	15	syndrome	syndrome	NOUN
ajird-1300	14	16	(	(	PUNCT
ajird-1300	14	17	ms	ms	NOUN
ajird-1300	14	18	)	)	PUNCT
ajird-1300	14	19	,	,	PUNCT
ajird-1300	14	20	such	such	ADJ
ajird-1300	14	21	as	as	ADP
ajird-1300	14	22	abdominal	abdominal	ADJ
ajird-1300	14	23	obesity	obesity	NOUN
ajird-1300	14	24	,	,	PUNCT
ajird-1300	14	25	dyslipidemia	dyslipidemia	NOUN
ajird-1300	14	26	,	,	PUNCT
ajird-1300	14	27	and	and	CCONJ
ajird-1300	14	28	insulin	insulin	NOUN
ajird-1300	14	29	resistance	resistance	NOUN
ajird-1300	14	30	,	,	PUNCT
ajird-1300	14	31	which	which	PRON
ajird-1300	14	32	are	be	AUX
ajird-1300	14	33	a	a	DET
ajird-1300	14	34	group	group	NOUN
ajird-1300	14	35	of	of	ADP
ajird-1300	14	36	risk	risk	NOUN
ajird-1300	14	37	factors	factor	NOUN
ajird-1300	14	38	for	for	ADP
ajird-1300	14	39	cardiovascular	cardiovascular	ADJ
ajird-1300	14	40	disease	disease	NOUN
ajird-1300	14	41	(	(	PUNCT
ajird-1300	14	42	cvd	cvd	PROPN
ajird-1300	14	43	)	)	PUNCT
ajird-1300	14	44	and	and	CCONJ
ajird-1300	14	45	type	type	NOUN
ajird-1300	14	46	2	2	NUM
ajird-1300	14	47	diabetes	diabetes	NOUN
ajird-1300	14	48	.	.	PUNCT
ajird-1300	15	1	accordingly	accordingly	ADV
ajird-1300	15	2	,	,	PUNCT
ajird-1300	15	3	in	in	ADP
ajird-1300	15	4	patients	patient	NOUN
ajird-1300	15	5	within	within	ADP
ajird-1300	15	6	overweight	overweight	NOUN
ajird-1300	15	7	or	or	CCONJ
ajird-1300	15	8	obese	obese	ADJ
ajird-1300	15	9	individuals	individual	NOUN
ajird-1300	15	10	,	,	PUNCT
ajird-1300	15	11	metabolic	metabolic	NOUN
ajird-1300	15	12	disorders	disorder	NOUN
ajird-1300	15	13	typical	typical	ADJ
ajird-1300	15	14	of	of	ADP
ajird-1300	15	15	ms	ms	NOUN
ajird-1300	15	16	could	could	AUX
ajird-1300	15	17	be	be	AUX
ajird-1300	15	18	associated	associate	VERB
ajird-1300	15	19	with	with	ADP
ajird-1300	15	20	dhrv	dhrv	PROPN
ajird-1300	15	21	,	,	PUNCT
ajird-1300	15	22	but	but	CCONJ
ajird-1300	15	23	could	could	AUX
ajird-1300	15	24	also	also	ADV
ajird-1300	15	25	exist	exist	VERB
ajird-1300	15	26	independently	independently	ADV
ajird-1300	15	27	of	of	ADP
ajird-1300	15	28	dhrv	dhrv	PROPN
ajird-1300	15	29	.	.	PUNCT
ajird-1300	16	1	in	in	ADP
ajird-1300	16	2	such	such	DET
ajird-1300	16	3	a	a	DET
ajird-1300	16	4	situation	situation	NOUN
ajird-1300	16	5	,	,	PUNCT
ajird-1300	16	6	cause	cause	VERB
ajird-1300	16	7	and	and	CCONJ
ajird-1300	16	8	effect	effect	NOUN
ajird-1300	16	9	can	can	AUX
ajird-1300	16	10	overlap	overlap	VERB
ajird-1300	16	11	;	;	PUNCT
ajird-1300	16	12	on	on	ADP
ajird-1300	16	13	the	the	DET
ajird-1300	16	14	one	one	NUM
ajird-1300	16	15	hand	hand	NOUN
ajird-1300	16	16	,	,	PUNCT
ajird-1300	16	17	obesity	obesity	NOUN
ajird-1300	16	18	and	and	CCONJ
ajird-1300	16	19	metabolic	metabolic	NOUN
ajird-1300	16	20	disorders	disorder	NOUN
ajird-1300	16	21	can	can	AUX
ajird-1300	16	22	be	be	AUX
ajird-1300	16	23	consequences	consequence	NOUN
ajird-1300	16	24	of	of	ADP
ajird-1300	16	25	dhrv	dhrv	PROPN
ajird-1300	16	26	,	,	PUNCT
ajird-1300	16	27	while	while	SCONJ
ajird-1300	16	28	on	on	ADP
ajird-1300	16	29	the	the	DET
ajird-1300	16	30	other	other	ADJ
ajird-1300	16	31	,	,	PUNCT
ajird-1300	16	32	obesity	obesity	NOUN
ajird-1300	16	33	itself	itself	PRON
ajird-1300	16	34	can	can	AUX
ajird-1300	16	35	cause	cause	VERB
ajird-1300	16	36	endocrine	endocrine	ADJ
ajird-1300	16	37	disorders.[5	disorders.[5	NOUN
ajird-1300	16	38	-	-	PUNCT
ajird-1300	16	39	7].this	7].this	NUM
ajird-1300	16	40	aspect	aspect	NOUN
ajird-1300	16	41	was	be	AUX
ajird-1300	16	42	taken	take	VERB
ajird-1300	16	43	into	into	ADP
ajird-1300	16	44	account	account	NOUN
ajird-1300	16	45	in	in	ADP
ajird-1300	16	46	the	the	DET
ajird-1300	16	47	biochemical	biochemical	ADJ
ajird-1300	16	48	diagnosis	diagnosis	NOUN
ajird-1300	16	49	of	of	ADP
ajird-1300	16	50	ghd	ghd	NOUN
ajird-1300	16	51	,	,	PUNCT
ajird-1300	16	52	and	and	CCONJ
ajird-1300	16	53	the	the	DET
ajird-1300	16	54	growth	growth	NOUN
ajird-1300	16	55	hormone	hormone	NOUN
ajird-1300	16	56	(	(	PUNCT
ajird-1300	16	57	gh	gh	PROPN
ajird-1300	16	58	)	)	PUNCT
ajird-1300	16	59	response	response	NOUN
ajird-1300	16	60	in	in	ADP
ajird-1300	16	61	stimulation	stimulation	NOUN
ajird-1300	16	62	tests	test	NOUN
ajird-1300	16	63	was	be	AUX
ajird-1300	16	64	standardized	standardize	VERB
ajird-1300	16	65	depending	depend	VERB
ajird-1300	16	66	on	on	ADP
ajird-1300	16	67	the	the	DET
ajird-1300	16	68	degree	degree	NOUN
ajird-1300	16	69	of	of	ADP
ajird-1300	16	70	existing	exist	VERB
ajird-1300	16	71	obesity.[10	obesity.[10	PROPN
ajird-1300	16	72	-	-	PUNCT
ajird-1300	16	73	13].however	13].however	PROPN
ajird-1300	16	74	,	,	PUNCT
ajird-1300	16	75	obesity	obesity	NOUN
ajird-1300	16	76	itself	itself	PRON
ajird-1300	16	77	can	can	AUX
ajird-1300	16	78	disrupt	disrupt	VERB
ajird-1300	16	79	not	not	PART
ajird-1300	16	80	only	only	ADV
ajird-1300	16	81	gh	gh	PROPN
ajird-1300	16	82	secretion	secretion	NOUN
ajird-1300	16	83	,	,	PUNCT
ajird-1300	16	84	but	but	CCONJ
ajird-1300	16	85	also	also	ADV
ajird-1300	16	86	the	the	DET
ajird-1300	16	87	clinical	clinical	ADJ
ajird-1300	16	88	manifestations	manifestation	NOUN
ajird-1300	16	89	of	of	ADP
ajird-1300	16	90	gh	gh	PROPN
ajird-1300	16	91	syndrome	syndrome	PROPN
ajird-1300	16	92	,	,	PUNCT
ajird-1300	16	93	as	as	ADV
ajird-1300	16	94	well	well	ADV
ajird-1300	16	95	as	as	ADP
ajird-1300	16	96	the	the	DET
ajird-1300	16	97	effects	effect	NOUN
ajird-1300	16	98	of	of	ADP
ajird-1300	16	99	gh	gh	PROPN
ajird-1300	16	100	therapy	therapy	NOUN
ajird-1300	16	101	.	.	PUNCT
ajird-1300	17	1	all	all	DET
ajird-1300	17	2	this	this	PRON
ajird-1300	17	3	indicates	indicate	VERB
ajird-1300	17	4	the	the	DET
ajird-1300	17	5	relevance	relevance	NOUN
ajird-1300	17	6	of	of	ADP
ajird-1300	17	7	the	the	DET
ajird-1300	17	8	chosen	choose	VERB
ajird-1300	17	9	topic	topic	NOUN
ajird-1300	17	10	and	and	CCONJ
ajird-1300	17	11	served	serve	VERB
ajird-1300	17	12	as	as	ADP
ajird-1300	17	13	the	the	DET
ajird-1300	17	14	reason	reason	NOUN
ajird-1300	17	15	for	for	ADP
ajird-1300	17	16	conducting	conduct	VERB
ajird-1300	17	17	this	this	DET
ajird-1300	17	18	study	study	NOUN
ajird-1300	17	19	.	.	PUNCT
ajird-1300	18	1	the	the	DET
ajird-1300	18	2	aim	aim	NOUN
ajird-1300	18	3	of	of	ADP
ajird-1300	18	4	the	the	DET
ajird-1300	18	5	study	study	NOUN
ajird-1300	18	6	is	be	AUX
ajird-1300	18	7	to	to	PART
ajird-1300	18	8	study	study	VERB
ajird-1300	18	9	the	the	DET
ajird-1300	18	10	metabolic	metabolic	NOUN
ajird-1300	18	11	outcomes	outcome	NOUN
ajird-1300	18	12	of	of	ADP
ajird-1300	18	13	ghd	ghd	NOUN
ajird-1300	18	14	in	in	ADP
ajird-1300	18	15	patients	patient	NOUN
ajird-1300	18	16	with	with	ADP
ajird-1300	18	17	coronary	coronary	ADJ
ajird-1300	18	18	heart	heart	NOUN
ajird-1300	18	19	disease	disease	NOUN
ajird-1300	18	20	(	(	PUNCT
ajird-1300	18	21	chd	chd	NOUN
ajird-1300	18	22	)	)	PUNCT
ajird-1300	18	23	.	.	PUNCT
ajird-1300	19	1	material	material	NOUN
ajird-1300	19	2	and	and	CCONJ
ajird-1300	19	3	methods	method	NOUN
ajird-1300	19	4	of	of	ADP
ajird-1300	19	5	research	research	NOUN
ajird-1300	19	6	we	we	PRON
ajird-1300	19	7	examined	examine	VERB
ajird-1300	19	8	21	21	NUM
ajird-1300	19	9	adult	adult	NOUN
ajird-1300	19	10	patients	patient	NOUN
ajird-1300	19	11	with	with	ADP
ajird-1300	19	12	coronary	coronary	ADJ
ajird-1300	19	13	heart	heart	NOUN
ajird-1300	19	14	disease	disease	NOUN
ajird-1300	19	15	and	and	CCONJ
ajird-1300	19	16	metabolic	metabolic	NOUN
ajird-1300	19	17	syndrome	syndrome	NOUN
ajird-1300	19	18	(	(	PUNCT
ajird-1300	19	19	ms	ms	NOUN
ajird-1300	19	20	)	)	PUNCT
ajird-1300	19	21	.	.	PUNCT
ajird-1300	20	1	of	of	ADP
ajird-1300	20	2	these	these	PRON
ajird-1300	20	3	,	,	PUNCT
ajird-1300	20	4	13	13	NUM
ajird-1300	20	5	were	be	AUX
ajird-1300	20	6	men	man	NOUN
ajird-1300	20	7	(	(	PUNCT
ajird-1300	20	8	61.9	61.9	NUM
ajird-1300	20	9	%	%	NOUN
ajird-1300	20	10	)	)	PUNCT
ajird-1300	20	11	and	and	CCONJ
ajird-1300	20	12	8	8	NUM
ajird-1300	20	13	were	be	AUX
ajird-1300	20	14	women	woman	NOUN
ajird-1300	20	15	(	(	PUNCT
ajird-1300	20	16	38	38	NUM
ajird-1300	20	17	%	%	NOUN
ajird-1300	20	18	)	)	PUNCT
ajird-1300	20	19	.	.	PUNCT
ajird-1300	21	1	the	the	DET
ajird-1300	21	2	average	average	ADJ
ajird-1300	21	3	age	age	NOUN
ajird-1300	21	4	was	be	AUX
ajird-1300	21	5	58.0	58.0	NUM
ajird-1300	21	6	years	year	NOUN
ajird-1300	21	7	for	for	ADP
ajird-1300	21	8	men	man	NOUN
ajird-1300	21	9	and	and	CCONJ
ajird-1300	21	10	58.2	58.2	NUM
ajird-1300	21	11	years	year	NOUN
ajird-1300	21	12	for	for	ADP
ajird-1300	21	13	women	woman	NOUN
ajird-1300	21	14	.	.	PUNCT
ajird-1300	22	1	the	the	DET
ajird-1300	22	2	duration	duration	NOUN
ajird-1300	22	3	of	of	ADP
ajird-1300	22	4	the	the	DET
ajird-1300	22	5	disease	disease	NOUN
ajird-1300	22	6	ranged	range	VERB
ajird-1300	22	7	from	from	ADP
ajird-1300	22	8	2	2	NUM
ajird-1300	22	9	months	month	NOUN
ajird-1300	22	10	to	to	ADP
ajird-1300	22	11	25	25	NUM
ajird-1300	22	12	years	year	NOUN
ajird-1300	22	13	.	.	PUNCT
ajird-1300	23	1	the	the	DET
ajird-1300	23	2	control	control	PROPN
ajird-1300	23	3	group	group	NOUN
ajird-1300	23	4	consisted	consist	VERB
ajird-1300	23	5	of	of	ADP
ajird-1300	23	6	20	20	NUM
ajird-1300	23	7	healthy	healthy	ADJ
ajird-1300	23	8	individuals	individual	NOUN
ajird-1300	23	9	of	of	ADP
ajird-1300	23	10	both	both	DET
ajird-1300	23	11	sexes	sex	NOUN
ajird-1300	23	12	of	of	ADP
ajird-1300	23	13	the	the	DET
ajird-1300	23	14	corresponding	corresponding	ADJ
ajird-1300	23	15	average	average	ADJ
ajird-1300	23	16	age	age	NOUN
ajird-1300	23	17	.	.	PUNCT
ajird-1300	24	1	the	the	DET
ajird-1300	24	2	research	research	NOUN
ajird-1300	24	3	methods	method	NOUN
ajird-1300	24	4	included	include	VERB
ajird-1300	24	5	:	:	PUNCT
ajird-1300	24	6	1	1	X
ajird-1300	24	7	)	)	PUNCT
ajird-1300	24	8	general	general	ADJ
ajird-1300	24	9	clinical	clinical	ADJ
ajird-1300	24	10	(	(	PUNCT
ajird-1300	24	11	examination	examination	NOUN
ajird-1300	24	12	of	of	ADP
ajird-1300	24	13	endocrine	endocrine	NOUN
ajird-1300	24	14	,	,	PUNCT
ajird-1300	24	15	neurological	neurological	ADJ
ajird-1300	24	16	and	and	CCONJ
ajird-1300	24	17	ophthalmological	ophthalmological	ADJ
ajird-1300	24	18	status	status	NOUN
ajird-1300	24	19	,	,	PUNCT
ajird-1300	24	20	anthropometry	anthropometry	NOUN
ajird-1300	24	21	height	height	NOUN
ajird-1300	24	22	,	,	PUNCT
ajird-1300	24	23	weight	weight	NOUN
ajird-1300	24	24	,	,	PUNCT
ajird-1300	24	25	wc	wc	PROPN
ajird-1300	24	26	,	,	PUNCT
ajird-1300	24	27	hc	hc	PROPN
ajird-1300	24	28	,	,	PUNCT
ajird-1300	24	29	bmi	bmi	NOUN
ajird-1300	24	30	,	,	PUNCT
ajird-1300	24	31	assessment	assessment	NOUN
ajird-1300	24	32	of	of	ADP
ajird-1300	24	33	dgrv	dgrv	NOUN
ajird-1300	24	34	according	accord	VERB
ajird-1300	24	35	to	to	ADP
ajird-1300	24	36	the	the	DET
ajird-1300	24	37	standard	standard	ADJ
ajird-1300	24	38	international	international	ADJ
ajird-1300	24	39	questionnaire	questionnaire	NOUN
ajird-1300	24	40	)	)	PUNCT
ajird-1300	24	41	,	,	PUNCT
ajird-1300	24	42	2	2	X
ajird-1300	24	43	)	)	PUNCT
ajird-1300	24	44	instrumental	instrumental	ADJ
ajird-1300	24	45	(	(	PUNCT
ajird-1300	24	46	fundus	fundus	NOUN
ajird-1300	24	47	,	,	PUNCT
ajird-1300	24	48	visual	visual	ADJ
ajird-1300	24	49	acuity	acuity	NOUN
ajird-1300	24	50	,	,	PUNCT
ajird-1300	24	51	ecg	ecg	PROPN
ajird-1300	24	52	,	,	PUNCT
ajird-1300	24	53	echo	echo	NOUN
ajird-1300	24	54	-	-	PUNCT
ajird-1300	24	55	ecg	ecg	PROPN
ajird-1300	24	56	,	,	PUNCT
ajird-1300	24	57	hm	hm	PROPN
ajird-1300	24	58	-	-	PUNCT
ajird-1300	24	59	ecg	ecg	PROPN
ajird-1300	24	60	,	,	PUNCT
ajird-1300	24	61	ultrasound	ultrasound	NOUN
ajird-1300	24	62	of	of	ADP
ajird-1300	24	63	internal	internal	ADJ
ajird-1300	24	64	organs	organ	NOUN
ajird-1300	24	65	,	,	PUNCT
ajird-1300	24	66	etc	etc	X
ajird-1300	24	67	.	.	X
ajird-1300	24	68	)	)	PUNCT
ajird-1300	24	69	,	,	PUNCT
ajird-1300	24	70	3	3	X
ajird-1300	24	71	)	)	PUNCT
ajird-1300	24	72	hormonal	hormonal	ADJ
ajird-1300	24	73	blood	blood	NOUN
ajird-1300	24	74	tests	test	NOUN
ajird-1300	24	75	(	(	PUNCT
ajird-1300	24	76	sth	sth	NOUN
ajird-1300	24	77	,	,	PUNCT
ajird-1300	24	78	igf-1	igf-1	NOUN
ajird-1300	24	79	,	,	PUNCT
ajird-1300	24	80	lh	lh	NOUN
ajird-1300	24	81	,	,	PUNCT
ajird-1300	24	82	fsh	fsh	PROPN
ajird-1300	24	83	,	,	PUNCT
ajird-1300	24	84	prl	prl	NOUN
ajird-1300	24	85	,	,	PUNCT
ajird-1300	24	86	tsh	tsh	ADJ
ajird-1300	24	87	,	,	PUNCT
ajird-1300	24	88	acth	acth	NOUN
ajird-1300	24	89	,	,	PUNCT
ajird-1300	24	90	prolactin	prolactin	NOUN
ajird-1300	24	91	,	,	PUNCT
ajird-1300	24	92	testosterone	testosterone	NOUN
ajird-1300	24	93	,	,	PUNCT
ajird-1300	24	94	estradiol	estradiol	PROPN
ajird-1300	24	95	,	,	PUNCT
ajird-1300	24	96	progesterone	progesterone	NOUN
ajird-1300	24	97	,	,	PUNCT
ajird-1300	24	98	cortisol	cortisol	NOUN
ajird-1300	24	99	,	,	PUNCT
ajird-1300	24	100	t3	t3	PROPN
ajird-1300	24	101	,	,	PUNCT
ajird-1300	24	102	t4	t4	PROPN
ajird-1300	24	103	)	)	PUNCT
ajird-1300	24	104	,	,	PUNCT
ajird-1300	24	105	4	4	X
ajird-1300	24	106	)	)	PUNCT
ajird-1300	24	107	general	general	ADJ
ajird-1300	24	108	clinical	clinical	ADJ
ajird-1300	24	109	and	and	CCONJ
ajird-1300	24	110	biochemical	biochemical	ADJ
ajird-1300	24	111	blood	blood	NOUN
ajird-1300	24	112	tests	test	NOUN
ajird-1300	24	113	(	(	PUNCT
ajird-1300	24	114	total	total	ADJ
ajird-1300	24	115	protein	protein	NOUN
ajird-1300	24	116	,	,	PUNCT
ajird-1300	24	117	fibrinogen	fibrinogen	NOUN
ajird-1300	24	118	,	,	PUNCT
ajird-1300	24	119	pti	pti	PROPN
ajird-1300	24	120	,	,	PUNCT
ajird-1300	24	121	alt	alt	ADJ
ajird-1300	24	122	,	,	PUNCT
ajird-1300	24	123	ast	ast	ADJ
ajird-1300	24	124	,	,	PUNCT
ajird-1300	24	125	total	total	ADJ
ajird-1300	24	126	zolesterol	zolesterol	NOUN
ajird-1300	24	127	,	,	PUNCT
ajird-1300	24	128	ldl	ldl	NOUN
ajird-1300	24	129	,	,	PUNCT
ajird-1300	24	130	vldl	vldl	PROPN
ajird-1300	24	131	,	,	PUNCT
ajird-1300	24	132	hdl	hdl	PROPN
ajird-1300	24	133	,	,	PUNCT
ajird-1300	24	134	triglycerides	triglyceride	NOUN
ajird-1300	24	135	,	,	PUNCT
ajird-1300	24	136	calcium	calcium	NOUN
ajird-1300	24	137	,	,	PUNCT
ajird-1300	24	138	coagulogram	coagulogram	PROPN
ajird-1300	24	139	,	,	PUNCT
ajird-1300	24	140	glucose	glucose	NOUN
ajird-1300	24	141	.	.	PUNCT
ajird-1300	25	1	blood	blood	NOUN
ajird-1300	25	2	,	,	PUNCT
ajird-1300	25	3	glycated	glycate	VERB
ajird-1300	25	4	hemoglobin	hemoglobin	NOUN
ajird-1300	25	5	,	,	PUNCT
ajird-1300	25	6	total	total	ADJ
ajird-1300	25	7	bilirubin	bilirubin	NOUN
ajird-1300	25	8	,	,	PUNCT
ajird-1300	25	9	direct	direct	ADJ
ajird-1300	25	10	bilirubin	bilirubin	NOUN
ajird-1300	25	11	,	,	PUNCT
ajird-1300	25	12	urea	urea	NOUN
ajird-1300	25	13	and	and	CCONJ
ajird-1300	25	14	creatinine	creatinine	NOUN
ajird-1300	25	15	,	,	PUNCT
ajird-1300	25	16	aslo	aslo	PROPN
ajird-1300	25	17	,	,	PUNCT
ajird-1300	25	18	crp	crp	PROPN
ajird-1300	25	19	,	,	PUNCT
ajird-1300	25	20	glucose	glucose	NOUN
ajird-1300	25	21	tolerance	tolerance	NOUN
ajird-1300	25	22	test	test	NOUN
ajird-1300	25	23	,	,	PUNCT
ajird-1300	25	24	etc	etc	X
ajird-1300	25	25	.	.	X
ajird-1300	25	26	)	)	PUNCT
ajird-1300	25	27	and	and	CCONJ
ajird-1300	25	28	urine	urine	NOUN
ajird-1300	25	29	.	.	PUNCT
ajird-1300	26	1	lipid	lipid	ADJ
ajird-1300	26	2	metabolism	metabolism	NOUN
ajird-1300	26	3	study	study	NOUN
ajird-1300	26	4	:	:	PUNCT
ajird-1300	26	5	total	total	ADJ
ajird-1300	26	6	cholesterol	cholesterol	NOUN
ajird-1300	26	7	and	and	CCONJ
ajird-1300	26	8	tg	tg	PROPN
ajird-1300	26	9	were	be	AUX
ajird-1300	26	10	determined	determine	VERB
ajird-1300	26	11	using	use	VERB
ajird-1300	26	12	tests	test	NOUN
ajird-1300	26	13	from	from	ADP
ajird-1300	26	14	the	the	DET
ajird-1300	26	15	company	company	NOUN
ajird-1300	26	16	"	"	PUNCT
ajird-1300	26	17	randox	randox	VERB
ajird-1300	26	18	»	»	PUNCT
ajird-1300	26	19	on	on	ADP
ajird-1300	26	20	the	the	DET
ajird-1300	26	21	autoanalyzer	autoanalyzer	PROPN
ajird-1300	26	22	«	«	PUNCT
ajird-1300	26	23	centrifichem-600	centrifichem-600	PROPN
ajird-1300	26	24	»	»	NOUN
ajird-1300	26	25	,	,	PUNCT
ajird-1300	26	26	hdl	hdl	PROPN
ajird-1300	26	27	-	-	PUNCT
ajird-1300	26	28	c	c	PROPN
ajird-1300	26	29	—	—	PUNCT
ajird-1300	26	30	on	on	ADP
ajird-1300	26	31	the	the	DET
ajird-1300	26	32	autoanalyzer	autoanalyzer	NOUN
ajird-1300	26	33	«	«	PUNCT
ajird-1300	26	34	technicon	technicon	NOUN
ajird-1300	26	35	aap	aap	PROPN
ajird-1300	26	36	»	»	PUNCT
ajird-1300	26	37	(	(	PUNCT
ajird-1300	26	38	usa	usa	PROPN
ajird-1300	26	39	)	)	PUNCT
ajird-1300	26	40	after	after	ADP
ajird-1300	26	41	precipitation	precipitation	NOUN
ajird-1300	26	42	from	from	ADP
ajird-1300	26	43	plasma	plasma	NOUN
ajird-1300	26	44	ldl	ldl	NOUN
ajird-1300	26	45	and	and	CCONJ
ajird-1300	26	46	vldl	vldl	NOUN
ajird-1300	26	47	with	with	ADP
ajird-1300	26	48	phosphotungstic	phosphotungstic	ADJ
ajird-1300	26	49	acid	acid	NOUN
ajird-1300	26	50	.	.	PUNCT
ajird-1300	27	1	the	the	DET
ajird-1300	27	2	level	level	NOUN
ajird-1300	27	3	of	of	ADP
ajird-1300	27	4	ldl	ldl	NOUN
ajird-1300	27	5	-	-	PUNCT
ajird-1300	27	6	c	c	PROPN
ajird-1300	27	7	and	and	CCONJ
ajird-1300	27	8	vldl	vldl	PROPN
ajird-1300	27	9	-	-	PUNCT
ajird-1300	27	10	c	c	PROPN
ajird-1300	27	11	was	be	AUX
ajird-1300	27	12	calculated	calculate	VERB
ajird-1300	27	13	according	accord	VERB
ajird-1300	27	14	to	to	ADP
ajird-1300	27	15	the	the	DET
ajird-1300	27	16	formulas	formula	NOUN
ajird-1300	27	17	of	of	ADP
ajird-1300	27	18	w.	w.	PROPN
ajird-1300	27	19	friedwald	friedwald	PROPN
ajird-1300	27	20	.	.	PUNCT
ajird-1300	28	1	american	american	PROPN
ajird-1300	28	2	journal	journal	PROPN
ajird-1300	28	3	of	of	ADP
ajird-1300	28	4	interdisciplinary	interdisciplinary	ADJ
ajird-1300	28	5	research	research	NOUN
ajird-1300	28	6	and	and	CCONJ
ajird-1300	28	7	development	development	NOUN
ajird-1300	28	8	issn	issn	PROPN
ajird-1300	28	9	online	online	NOUN
ajird-1300	28	10	:	:	PUNCT
ajird-1300	28	11	2771	2771	NUM
ajird-1300	28	12	-	-	SYM
ajird-1300	28	13	8948	8948	NUM
ajird-1300	28	14	website	website	NOUN
ajird-1300	28	15	:	:	PUNCT
ajird-1300	28	16	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-1300	28	17	volume	volume	NOUN
ajird-1300	28	18	33	33	NUM
ajird-1300	28	19	,	,	PUNCT
ajird-1300	28	20	october	october	PROPN
ajird-1300	28	21	2024	2024	NUM
ajird-1300	28	22	8	8	NUM
ajird-1300	29	1	|	|	ADV
ajird-1300	29	2	p	p	X
ajird-1300	29	3	a	a	DET
ajird-1300	29	4	g	g	NOUN
ajird-1300	29	5	e	e	NOUN
ajird-1300	29	6	all	all	DET
ajird-1300	29	7	patient	patient	ADJ
ajird-1300	29	8	data	datum	NOUN
ajird-1300	29	9	were	be	AUX
ajird-1300	29	10	entered	enter	VERB
ajird-1300	29	11	into	into	ADP
ajird-1300	29	12	the	the	DET
ajird-1300	29	13	computer	computer	NOUN
ajird-1300	29	14	database	database	NOUN
ajird-1300	29	15	we	we	PRON
ajird-1300	29	16	created	create	VERB
ajird-1300	29	17	,	,	PUNCT
ajird-1300	29	18	“	"	PUNCT
ajird-1300	29	19	volumetric	volumetric	ADJ
ajird-1300	29	20	formations	formation	NOUN
ajird-1300	29	21	of	of	ADP
ajird-1300	29	22	the	the	DET
ajird-1300	29	23	hypothalamic	hypothalamic	ADJ
ajird-1300	29	24	-	-	PUNCT
ajird-1300	29	25	pituitary	pituitary	ADJ
ajird-1300	29	26	system	system	NOUN
ajird-1300	29	27	with	with	ADP
ajird-1300	29	28	growth	growth	NOUN
ajird-1300	29	29	hormone	hormone	NOUN
ajird-1300	29	30	deficiency	deficiency	NOUN
ajird-1300	29	31	,	,	PUNCT
ajird-1300	29	32	”	"	PUNCT
ajird-1300	29	33	for	for	ADP
ajird-1300	29	34	further	further	ADJ
ajird-1300	29	35	statistical	statistical	ADJ
ajird-1300	29	36	processing	processing	NOUN
ajird-1300	29	37	(	(	PUNCT
ajird-1300	29	38	intellectual	intellectual	ADJ
ajird-1300	29	39	property	property	NOUN
ajird-1300	29	40	agency	agency	NOUN
ajird-1300	29	41	of	of	ADP
ajird-1300	29	42	the	the	DET
ajird-1300	29	43	republic	republic	NOUN
ajird-1300	29	44	of	of	ADP
ajird-1300	29	45	uzbekistan	uzbekistan	PROPN
ajird-1300	29	46	,	,	PUNCT
ajird-1300	29	47	certificate	certificate	NOUN
ajird-1300	29	48	of	of	ADP
ajird-1300	29	49	registration	registration	NOUN
ajird-1300	29	50	bgu	bgu	NOUN
ajird-1300	29	51	00263	00263	NUM
ajird-1300	29	52	dated	date	VERB
ajird-1300	29	53	25.03	25.03	NUM
ajird-1300	29	54	.	.	X
ajird-1300	30	1	2011	2011	NUM
ajird-1300	30	2	tashkent	tashkent	NOUN
ajird-1300	30	3	,	,	PUNCT
ajird-1300	30	4	shakirova	shakirova	X
ajird-1300	30	5	m.yu	m.yu	PROPN
ajird-1300	30	6	.	.	PROPN
ajird-1300	30	7	,	,	PUNCT
ajird-1300	30	8	urmanova	urmanova	PROPN
ajird-1300	30	9	yu.m	yu.m	PROPN
ajird-1300	30	10	.	.	PUNCT
ajird-1300	30	11	)	)	PUNCT
ajird-1300	31	1	the	the	DET
ajird-1300	31	2	obtained	obtain	VERB
ajird-1300	31	3	data	datum	NOUN
ajird-1300	31	4	were	be	AUX
ajird-1300	31	5	processed	process	VERB
ajird-1300	31	6	using	use	VERB
ajird-1300	31	7	the	the	DET
ajird-1300	31	8	computer	computer	NOUN
ajird-1300	31	9	programs	program	NOUN
ajird-1300	31	10	microsoft	microsoft	PROPN
ajird-1300	31	11	excel	excel	VERB
ajird-1300	31	12	and	and	CCONJ
ajird-1300	31	13	statistica_6	statistica_6	PROPN
ajird-1300	31	14	.	.	PUNCT
ajird-1300	32	1	differences	difference	NOUN
ajird-1300	32	2	between	between	ADP
ajird-1300	32	3	groups	group	NOUN
ajird-1300	32	4	were	be	AUX
ajird-1300	32	5	considered	consider	VERB
ajird-1300	32	6	statistically	statistically	ADV
ajird-1300	32	7	significant	significant	ADJ
ajird-1300	32	8	at	at	ADP
ajird-1300	32	9	p	p	NOUN
ajird-1300	32	10	0.05	0.05	NUM
ajird-1300	32	11	.	.	PUNCT
ajird-1300	33	1	the	the	DET
ajird-1300	33	2	reliability	reliability	NOUN
ajird-1300	33	3	of	of	ADP
ajird-1300	33	4	differences	difference	NOUN
ajird-1300	33	5	in	in	ADP
ajird-1300	33	6	the	the	DET
ajird-1300	33	7	level	level	NOUN
ajird-1300	33	8	between	between	ADP
ajird-1300	33	9	groups	group	NOUN
ajird-1300	33	10	was	be	AUX
ajird-1300	33	11	assessed	assess	VERB
ajird-1300	33	12	by	by	ADP
ajird-1300	33	13	the	the	DET
ajird-1300	33	14	value	value	NOUN
ajird-1300	33	15	of	of	ADP
ajird-1300	33	16	the	the	DET
ajird-1300	33	17	confidence	confidence	NOUN
ajird-1300	33	18	interval	interval	NOUN
ajird-1300	33	19	and	and	CCONJ
ajird-1300	33	20	the	the	DET
ajird-1300	33	21	student	student	NOUN
ajird-1300	33	22	's	's	PART
ajird-1300	33	23	criterion	criterion	NOUN
ajird-1300	33	24	(	(	PUNCT
ajird-1300	33	25	p	p	NOUN
ajird-1300	33	26	)	)	PUNCT
ajird-1300	33	27	.	.	PUNCT
ajird-1300	34	1	differences	difference	NOUN
ajird-1300	34	2	were	be	AUX
ajird-1300	34	3	considered	consider	VERB
ajird-1300	34	4	statistically	statistically	ADV
ajird-1300	34	5	significant	significant	ADJ
ajird-1300	34	6	at	at	ADP
ajird-1300	34	7	p	p	X
ajird-1300	34	8	<	<	X
ajird-1300	34	9	0.05	0.05	NUM
ajird-1300	34	10	.	.	PUNCT
ajird-1300	35	1	research	research	NOUN
ajird-1300	35	2	results	result	NOUN
ajird-1300	35	3	and	and	CCONJ
ajird-1300	35	4	their	their	PRON
ajird-1300	35	5	discussion	discussion	NOUN
ajird-1300	35	6	.	.	PUNCT
ajird-1300	36	1	table	table	NOUN
ajird-1300	36	2	1	1	NUM
ajird-1300	36	3	shows	show	VERB
ajird-1300	36	4	the	the	DET
ajird-1300	36	5	distribution	distribution	NOUN
ajird-1300	36	6	of	of	ADP
ajird-1300	36	7	patients	patient	NOUN
ajird-1300	36	8	by	by	ADP
ajird-1300	36	9	gender	gender	NOUN
ajird-1300	36	10	and	and	CCONJ
ajird-1300	36	11	age	age	NOUN
ajird-1300	36	12	.	.	PUNCT
ajird-1300	37	1	table	table	NOUN
ajird-1300	37	2	3	3	NUM
ajird-1300	37	3	.	.	PUNCT
ajird-1300	38	1	distribution	distribution	NOUN
ajird-1300	38	2	of	of	ADP
ajird-1300	38	3	patients	patient	NOUN
ajird-1300	38	4	by	by	ADP
ajird-1300	38	5	gender	gender	NOUN
ajird-1300	38	6	and	and	CCONJ
ajird-1300	38	7	age	age	NOUN
ajird-1300	38	8	(	(	PUNCT
ajird-1300	38	9	according	accord	VERB
ajird-1300	38	10	to	to	ADP
ajird-1300	38	11	who	who	PRON
ajird-1300	38	12	)	)	PUNCT
ajird-1300	38	13	age	age	NOUN
ajird-1300	38	14	,	,	PUNCT
ajird-1300	38	15	years	year	NOUN
ajird-1300	38	16	number	number	NOUN
ajird-1300	38	17	of	of	ADP
ajird-1300	38	18	men	man	NOUN
ajird-1300	38	19	(	(	PUNCT
ajird-1300	38	20	%	%	INTJ
ajird-1300	38	21	)	)	PUNCT
ajird-1300	38	22	number	number	NOUN
ajird-1300	38	23	of	of	ADP
ajird-1300	38	24	women	woman	NOUN
ajird-1300	38	25	(	(	PUNCT
ajird-1300	38	26	%	%	INTJ
ajird-1300	38	27	)	)	PUNCT
ajird-1300	38	28	16	16	NUM
ajird-1300	38	29	–	–	PUNCT
ajird-1300	38	30	29	29	NUM
ajird-1300	38	31	30	30	NUM
ajird-1300	38	32	-	-	SYM
ajird-1300	38	33	44	44	NUM
ajird-1300	38	34	1	1	NUM
ajird-1300	38	35	(	(	PUNCT
ajird-1300	38	36	12.5	12.5	NUM
ajird-1300	38	37	%	%	NOUN
ajird-1300	38	38	)	)	PUNCT
ajird-1300	38	39	45	45	NUM
ajird-1300	38	40	-	-	SYM
ajird-1300	38	41	59	59	NUM
ajird-1300	38	42	9	9	NUM
ajird-1300	38	43	(	(	PUNCT
ajird-1300	38	44	69.2	69.2	NUM
ajird-1300	38	45	%	%	NOUN
ajird-1300	38	46	)	)	PUNCT
ajird-1300	38	47	4	4	NUM
ajird-1300	38	48	(	(	PUNCT
ajird-1300	38	49	50	50	NUM
ajird-1300	38	50	%	%	NOUN
ajird-1300	38	51	)	)	PUNCT
ajird-1300	38	52	60	60	NUM
ajird-1300	38	53	-	-	SYM
ajird-1300	38	54	74	74	NUM
ajird-1300	38	55	4(30.7	4(30.7	NOUN
ajird-1300	38	56	%	%	NOUN
ajird-1300	38	57	)	)	PUNCT
ajird-1300	38	58	3	3	NUM
ajird-1300	38	59	(	(	PUNCT
ajird-1300	38	60	38	38	NUM
ajird-1300	38	61	%	%	NOUN
ajird-1300	38	62	)	)	PUNCT
ajird-1300	38	63	75	75	NUM
ajird-1300	38	64	and	and	CCONJ
ajird-1300	38	65	art	art	NOUN
ajird-1300	38	66	.	.	PUNCT
ajird-1300	39	1	total	total	NOUN
ajird-1300	39	2	:	:	PUNCT
ajird-1300	39	3	21	21	NUM
ajird-1300	39	4	13	13	NUM
ajird-1300	39	5	(	(	PUNCT
ajird-1300	39	6	61.9	61.9	NUM
ajird-1300	39	7	%	%	NOUN
ajird-1300	39	8	)	)	PUNCT
ajird-1300	39	9	8	8	NUM
ajird-1300	39	10	(	(	PUNCT
ajird-1300	39	11	38	38	NUM
ajird-1300	39	12	%	%	NOUN
ajird-1300	39	13	)	)	PUNCT
ajird-1300	39	14	table	table	NOUN
ajird-1300	39	15	1	1	NUM
ajird-1300	39	16	shows	show	VERB
ajird-1300	39	17	that	that	SCONJ
ajird-1300	39	18	most	most	ADV
ajird-1300	39	19	often	often	ADV
ajird-1300	39	20	the	the	DET
ajird-1300	39	21	patients	patient	NOUN
ajird-1300	39	22	were	be	AUX
ajird-1300	39	23	aged	age	VERB
ajird-1300	39	24	45	45	NUM
ajird-1300	39	25	to	to	PART
ajird-1300	39	26	59	59	NUM
ajird-1300	39	27	years	year	NOUN
ajird-1300	39	28	13	13	NUM
ajird-1300	39	29	patients	patient	NOUN
ajird-1300	39	30	(	(	PUNCT
ajird-1300	39	31	61.9	61.9	NUM
ajird-1300	39	32	%	%	NOUN
ajird-1300	39	33	)	)	PUNCT
ajird-1300	39	34	,	,	PUNCT
ajird-1300	39	35	that	that	ADV
ajird-1300	39	36	is	is	ADV
ajird-1300	39	37	,	,	PUNCT
ajird-1300	39	38	still	still	ADV
ajird-1300	39	39	of	of	ADP
ajird-1300	39	40	working	work	VERB
ajird-1300	39	41	age	age	NOUN
ajird-1300	39	42	.	.	PUNCT
ajird-1300	40	1	next	next	ADV
ajird-1300	40	2	,	,	PUNCT
ajird-1300	40	3	we	we	PRON
ajird-1300	40	4	studied	study	VERB
ajird-1300	40	5	the	the	DET
ajird-1300	40	6	clinical	clinical	ADJ
ajird-1300	40	7	and	and	CCONJ
ajird-1300	40	8	anamnestic	anamnestic	ADJ
ajird-1300	40	9	characteristics	characteristic	NOUN
ajird-1300	40	10	of	of	ADP
ajird-1300	40	11	the	the	DET
ajird-1300	40	12	patients	patient	NOUN
ajird-1300	40	13	.	.	PUNCT
ajird-1300	41	1	table	table	NOUN
ajird-1300	41	2	2	2	NUM
ajird-1300	41	3	.	.	PUNCT
ajird-1300	42	1	distribution	distribution	NOUN
ajird-1300	42	2	of	of	ADP
ajird-1300	42	3	patients	patient	NOUN
ajird-1300	42	4	into	into	ADP
ajird-1300	42	5	groups	group	NOUN
ajird-1300	42	6	patient	patient	ADJ
ajird-1300	42	7	groups	group	NOUN
ajird-1300	42	8	number	number	NOUN
ajird-1300	42	9	of	of	ADP
ajird-1300	42	10	men	man	NOUN
ajird-1300	42	11	(	(	PUNCT
ajird-1300	42	12	%	%	NOUN
ajird-1300	42	13	)	)	PUNCT
ajird-1300	42	14	number	number	NOUN
ajird-1300	42	15	of	of	ADP
ajird-1300	42	16	women	woman	NOUN
ajird-1300	42	17	(	(	PUNCT
ajird-1300	42	18	%	%	INTJ
ajird-1300	42	19	)	)	PUNCT
ajird-1300	42	20	1	1	NUM
ajird-1300	42	21	.	.	X
ajird-1300	42	22	ihd	ihd	PROPN
ajird-1300	42	23	.	.	PUNCT
ajird-1300	43	1	angina	angina	PROPN
ajird-1300	43	2	pectoris	pectoris	PROPN
ajird-1300	43	3	fcii	fcii	PROPN
ajird-1300	43	4	2	2	NUM
ajird-1300	43	5	(	(	PUNCT
ajird-1300	43	6	15.4	15.4	NUM
ajird-1300	43	7	%	%	NOUN
ajird-1300	43	8	)	)	PUNCT
ajird-1300	43	9	2	2	NUM
ajird-1300	43	10	(	(	PUNCT
ajird-1300	43	11	25	25	NUM
ajird-1300	43	12	%	%	NOUN
ajird-1300	43	13	)	)	PUNCT
ajird-1300	44	1	2	2	NUM
ajird-1300	44	2	.	.	X
ajird-1300	44	3	ihd	ihd	PROPN
ajird-1300	44	4	.	.	PUNCT
ajird-1300	45	1	angina	angina	PROPN
ajird-1300	45	2	pectoris	pectoris	PROPN
ajird-1300	45	3	fc	fc	PROPN
ajird-1300	45	4	iii	iii	X
ajird-1300	45	5	11	11	NUM
ajird-1300	45	6	(	(	PUNCT
ajird-1300	45	7	84.6	84.6	NUM
ajird-1300	45	8	%	%	NOUN
ajird-1300	45	9	)	)	PUNCT
ajird-1300	45	10	6	6	NUM
ajird-1300	45	11	(	(	PUNCT
ajird-1300	45	12	75	75	NUM
ajird-1300	45	13	%	%	NOUN
ajird-1300	45	14	)	)	PUNCT
ajird-1300	45	15	total	total	NOUN
ajird-1300	45	16	:	:	PUNCT
ajird-1300	45	17	13	13	NUM
ajird-1300	45	18	8	8	NUM
ajird-1300	45	19	table	table	NOUN
ajird-1300	45	20	2	2	NUM
ajird-1300	45	21	shows	show	VERB
ajird-1300	45	22	the	the	DET
ajird-1300	45	23	distribution	distribution	NOUN
ajird-1300	45	24	of	of	ADP
ajird-1300	45	25	patients	patient	NOUN
ajird-1300	45	26	into	into	ADP
ajird-1300	45	27	groups	group	NOUN
ajird-1300	45	28	depending	depend	VERB
ajird-1300	45	29	on	on	ADP
ajird-1300	45	30	the	the	DET
ajird-1300	45	31	severity	severity	NOUN
ajird-1300	45	32	of	of	ADP
ajird-1300	45	33	the	the	DET
ajird-1300	45	34	underlying	underlie	VERB
ajird-1300	45	35	disease	disease	NOUN
ajird-1300	45	36	.	.	PUNCT
ajird-1300	46	1	patients	patient	NOUN
ajird-1300	46	2	were	be	AUX
ajird-1300	46	3	divided	divide	VERB
ajird-1300	46	4	into	into	ADP
ajird-1300	46	5	2	2	NUM
ajird-1300	46	6	main	main	ADJ
ajird-1300	46	7	groups	group	NOUN
ajird-1300	46	8	:	:	PUNCT
ajird-1300	46	9	group	group	NOUN
ajird-1300	46	10	1	1	NUM
ajird-1300	46	11	–	–	PUNCT
ajird-1300	46	12	patients	patient	NOUN
ajird-1300	46	13	with	with	ADP
ajird-1300	46	14	coronary	coronary	ADJ
ajird-1300	46	15	artery	artery	NOUN
ajird-1300	46	16	disease	disease	NOUN
ajird-1300	46	17	.	.	PUNCT
ajird-1300	47	1	angina	angina	PROPN
ajird-1300	47	2	pectoris	pectoris	PROPN
ajird-1300	47	3	.	.	PUNCT
ajird-1300	48	1	fcii	fcii	ADJ
ajird-1300	48	2	–	–	PUNCT
ajird-1300	48	3	4	4	NUM
ajird-1300	48	4	patients	patient	NOUN
ajird-1300	48	5	(	(	PUNCT
ajird-1300	48	6	19.0	19.0	NUM
ajird-1300	48	7	%	%	NOUN
ajird-1300	48	8	)	)	PUNCT
ajird-1300	48	9	,	,	PUNCT
ajird-1300	48	10	group	group	NOUN
ajird-1300	48	11	2	2	NUM
ajird-1300	48	12	-patients	-patient	NOUN
ajird-1300	48	13	with	with	ADP
ajird-1300	48	14	ischemic	ischemic	ADJ
ajird-1300	48	15	heart	heart	NOUN
ajird-1300	48	16	disease	disease	NOUN
ajird-1300	48	17	.	.	PUNCT
ajird-1300	49	1	angina	angina	PROPN
ajird-1300	49	2	pectoris	pectoris	PROPN
ajird-1300	49	3	.	.	PUNCT
ajird-1300	50	1	fciii	fciii	INTJ
ajird-1300	50	2	–	–	PUNCT
ajird-1300	50	3	17	17	NUM
ajird-1300	50	4	(	(	PUNCT
ajird-1300	50	5	81.0	81.0	NUM
ajird-1300	50	6	%	%	NOUN
ajird-1300	50	7	)	)	PUNCT
ajird-1300	50	8	.	.	PUNCT
ajird-1300	51	1	the	the	DET
ajird-1300	51	2	study	study	NOUN
ajird-1300	51	3	of	of	ADP
ajird-1300	51	4	the	the	DET
ajird-1300	51	5	anamnesis	anamnesis	NOUN
ajird-1300	51	6	showed	show	VERB
ajird-1300	51	7	that	that	SCONJ
ajird-1300	51	8	in	in	ADP
ajird-1300	51	9	10	10	NUM
ajird-1300	51	10	(	(	PUNCT
ajird-1300	51	11	47.6	47.6	NUM
ajird-1300	51	12	%	%	NOUN
ajird-1300	51	13	)	)	PUNCT
ajird-1300	51	14	cases	case	NOUN
ajird-1300	51	15	of	of	ADP
ajird-1300	51	16	our	our	PRON
ajird-1300	51	17	patients	patient	NOUN
ajird-1300	51	18	postinfarction	postinfarction	NOUN
ajird-1300	51	19	cardiosclerosis	cardiosclerosis	NOUN
ajird-1300	51	20	was	be	AUX
ajird-1300	51	21	established	establish	VERB
ajird-1300	51	22	,	,	PUNCT
ajird-1300	51	23	in	in	ADP
ajird-1300	51	24	2	2	NUM
ajird-1300	51	25	(	(	PUNCT
ajird-1300	51	26	9.5	9.5	NUM
ajird-1300	51	27	%	%	NOUN
ajird-1300	51	28	)	)	PUNCT
ajird-1300	51	29	cases	case	VERB
ajird-1300	51	30	coronary	coronary	ADJ
ajird-1300	51	31	artery	artery	NOUN
ajird-1300	51	32	stenting	stenting	NOUN
ajird-1300	51	33	was	be	AUX
ajird-1300	51	34	performed	perform	VERB
ajird-1300	51	35	,	,	PUNCT
ajird-1300	51	36	american	american	ADJ
ajird-1300	51	37	journal	journal	PROPN
ajird-1300	51	38	of	of	ADP
ajird-1300	51	39	interdisciplinary	interdisciplinary	ADJ
ajird-1300	51	40	research	research	NOUN
ajird-1300	51	41	and	and	CCONJ
ajird-1300	51	42	development	development	NOUN
ajird-1300	51	43	issn	issn	PROPN
ajird-1300	51	44	online	online	NOUN
ajird-1300	51	45	:	:	PUNCT
ajird-1300	51	46	2771	2771	NUM
ajird-1300	51	47	-	-	SYM
ajird-1300	51	48	8948	8948	NUM
ajird-1300	51	49	website	website	NOUN
ajird-1300	51	50	:	:	PUNCT
ajird-1300	51	51	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-1300	51	52	volume	volume	NOUN
ajird-1300	51	53	33	33	NUM
ajird-1300	51	54	,	,	PUNCT
ajird-1300	51	55	october	october	PROPN
ajird-1300	51	56	2024	2024	NUM
ajird-1300	51	57	9	9	NUM
ajird-1300	51	58	|	|	ADV
ajird-1300	51	59	p	p	X
ajird-1300	51	60	a	a	DET
ajird-1300	51	61	g	g	NOUN
ajird-1300	51	62	e	e	NOUN
ajird-1300	51	63	in	in	ADP
ajird-1300	51	64	1	1	NUM
ajird-1300	51	65	(	(	PUNCT
ajird-1300	51	66	4.7	4.7	NUM
ajird-1300	51	67	%	%	NOUN
ajird-1300	51	68	)	)	PUNCT
ajird-1300	51	69	aortocoronary	aortocoronary	ADJ
ajird-1300	51	70	bypass	bypass	NOUN
ajird-1300	51	71	grafting	grafting	NOUN
ajird-1300	51	72	.	.	PUNCT
ajird-1300	52	1	table	table	NOUN
ajird-1300	52	2	3	3	NUM
ajird-1300	52	3	provides	provide	VERB
ajird-1300	52	4	characteristics	characteristic	NOUN
ajird-1300	52	5	of	of	ADP
ajird-1300	52	6	concomitant	concomitant	ADJ
ajird-1300	52	7	diseases	disease	NOUN
ajird-1300	52	8	and	and	CCONJ
ajird-1300	52	9	complications	complication	NOUN
ajird-1300	52	10	of	of	ADP
ajird-1300	52	11	patients	patient	NOUN
ajird-1300	52	12	.	.	PUNCT
ajird-1300	53	1	table	table	NOUN
ajird-1300	53	2	3	3	NUM
ajird-1300	53	3	.	.	PUNCT
ajird-1300	54	1	characteristics	characteristic	NOUN
ajird-1300	54	2	of	of	ADP
ajird-1300	54	3	concomitant	concomitant	ADJ
ajird-1300	54	4	diseases	disease	NOUN
ajird-1300	54	5	and	and	CCONJ
ajird-1300	54	6	complications	complication	NOUN
ajird-1300	54	7	of	of	ADP
ajird-1300	54	8	the	the	DET
ajird-1300	54	9	underlying	underlie	VERB
ajird-1300	54	10	disease	disease	NOUN
ajird-1300	54	11	in	in	ADP
ajird-1300	54	12	patients	patient	NOUN
ajird-1300	54	13	by	by	ADP
ajird-1300	54	14	groups	group	NOUN
ajird-1300	54	15	associated	associate	VERB
ajird-1300	54	16	diseases	disease	NOUN
ajird-1300	54	17	and	and	CCONJ
ajird-1300	54	18	complications	complication	NOUN
ajird-1300	54	19	1	1	NUM
ajird-1300	54	20	group	group	NOUN
ajird-1300	54	21	(	(	PUNCT
ajird-1300	54	22	%	%	NOUN
ajird-1300	54	23	)	)	PUNCT
ajird-1300	54	24	2	2	NUM
ajird-1300	54	25	group	group	NOUN
ajird-1300	54	26	(	(	PUNCT
ajird-1300	54	27	%	%	NOUN
ajird-1300	54	28	)	)	PUNCT
ajird-1300	54	29	1	1	X
ajird-1300	54	30	.	.	X
ajird-1300	55	1	obesity	obesity	NOUN
ajird-1300	55	2	1	1	NUM
ajird-1300	55	3	-	-	SYM
ajird-1300	55	4	2	2	NUM
ajird-1300	55	5	tbsp	tbsp	NOUN
ajird-1300	55	6	.	.	PUNCT
ajird-1300	56	1	4	4	NUM
ajird-1300	56	2	(	(	PUNCT
ajird-1300	56	3	100	100	NUM
ajird-1300	56	4	%	%	NOUN
ajird-1300	56	5	)	)	PUNCT
ajird-1300	56	6	16	16	NUM
ajird-1300	56	7	(	(	PUNCT
ajird-1300	56	8	94.2	94.2	NUM
ajird-1300	56	9	%	%	NOUN
ajird-1300	56	10	)	)	PUNCT
ajird-1300	56	11	2	2	NUM
ajird-1300	56	12	.	.	X
ajird-1300	56	13	hypertension	hypertension	NOUN
ajird-1300	56	14	.	.	PUNCT
ajird-1300	57	1	2	2	NUM
ajird-1300	57	2	-	-	SYM
ajird-1300	57	3	3	3	NUM
ajird-1300	57	4	st	st	PROPN
ajird-1300	57	5	.	.	PROPN
ajird-1300	57	6	3	3	NUM
ajird-1300	57	7	(	(	PUNCT
ajird-1300	57	8	75	75	NUM
ajird-1300	57	9	%	%	NOUN
ajird-1300	57	10	)	)	PUNCT
ajird-1300	57	11	15	15	NUM
ajird-1300	57	12	(	(	PUNCT
ajird-1300	57	13	88.2	88.2	NUM
ajird-1300	57	14	%	%	NOUN
ajird-1300	57	15	)	)	PUNCT
ajird-1300	57	16	3	3	NUM
ajird-1300	57	17	.	.	X
ajird-1300	58	1	diabetes	diabetes	NOUN
ajird-1300	58	2	mellitus	mellitus	NOUN
ajird-1300	58	3	type	type	VERB
ajird-1300	58	4	2	2	NUM
ajird-1300	58	5	.	.	SYM
ajird-1300	58	6	2	2	NUM
ajird-1300	58	7	(	(	PUNCT
ajird-1300	58	8	50	50	NUM
ajird-1300	58	9	%	%	NOUN
ajird-1300	58	10	)	)	PUNCT
ajird-1300	58	11	5	5	NUM
ajird-1300	58	12	(	(	PUNCT
ajird-1300	58	13	29.4	29.4	NUM
ajird-1300	58	14	%	%	NOUN
ajird-1300	58	15	)	)	PUNCT
ajird-1300	58	16	4	4	NUM
ajird-1300	58	17	.	.	X
ajird-1300	59	1	osteochondrosis	osteochondrosis	NOUN
ajird-1300	59	2	of	of	ADP
ajird-1300	59	3	the	the	DET
ajird-1300	59	4	spine	spine	ADJ
ajird-1300	59	5	1	1	NUM
ajird-1300	59	6	(	(	PUNCT
ajird-1300	59	7	25	25	NUM
ajird-1300	59	8	%	%	NOUN
ajird-1300	59	9	)	)	PUNCT
ajird-1300	59	10	6	6	NUM
ajird-1300	59	11	(	(	PUNCT
ajird-1300	59	12	35.2	35.2	NUM
ajird-1300	59	13	%	%	NOUN
ajird-1300	59	14	)	)	PUNCT
ajird-1300	59	15	5	5	NUM
ajird-1300	59	16	.	.	X
ajird-1300	59	17	chronic	chronic	ADJ
ajird-1300	59	18	cholecystitis	cholecystitis	NOUN
ajird-1300	59	19	1	1	NUM
ajird-1300	59	20	(	(	PUNCT
ajird-1300	59	21	25	25	NUM
ajird-1300	59	22	%	%	NOUN
ajird-1300	59	23	)	)	PUNCT
ajird-1300	59	24	1	1	NUM
ajird-1300	59	25	(	(	PUNCT
ajird-1300	59	26	5.9	5.9	NUM
ajird-1300	59	27	%	%	NOUN
ajird-1300	59	28	)	)	PUNCT
ajird-1300	59	29	6	6	NUM
ajird-1300	59	30	.	.	X
ajird-1300	60	1	chronic	chronic	ADJ
ajird-1300	60	2	pyelonephritis	pyelonephritis	NOUN
ajird-1300	60	3	4	4	NUM
ajird-1300	60	4	(	(	PUNCT
ajird-1300	60	5	23.5	23.5	NUM
ajird-1300	60	6	%	%	NOUN
ajird-1300	60	7	)	)	PUNCT
ajird-1300	60	8	7	7	NUM
ajird-1300	60	9	.	.	X
ajird-1300	60	10	spontaneous	spontaneous	ADJ
ajird-1300	60	11	hypothyroidism	hypothyroidism	NOUN
ajird-1300	60	12	1	1	NUM
ajird-1300	60	13	(	(	PUNCT
ajird-1300	60	14	25	25	NUM
ajird-1300	60	15	%	%	NOUN
ajird-1300	60	16	)	)	PUNCT
ajird-1300	60	17	1	1	NUM
ajird-1300	60	18	(	(	PUNCT
ajird-1300	60	19	5.9	5.9	NUM
ajird-1300	60	20	%	%	NOUN
ajird-1300	60	21	)	)	PUNCT
ajird-1300	60	22	8	8	NUM
ajird-1300	60	23	.	.	PUNCT
ajird-1300	61	1	hypochromic	hypochromic	ADJ
ajird-1300	61	2	anemia	anemia	NOUN
ajird-1300	61	3	2nd	2nd	NOUN
ajird-1300	61	4	degree	degree	NOUN
ajird-1300	61	5	.	.	PUNCT
ajird-1300	62	1	1	1	NUM
ajird-1300	62	2	(	(	PUNCT
ajird-1300	62	3	5.9	5.9	NUM
ajird-1300	62	4	%	%	NOUN
ajird-1300	62	5	)	)	PUNCT
ajird-1300	62	6	9	9	NUM
ajird-1300	62	7	.	.	X
ajird-1300	62	8	chronic	chronic	ADJ
ajird-1300	62	9	gastritis	gastritis	NOUN
ajird-1300	62	10	1	1	NUM
ajird-1300	62	11	(	(	PUNCT
ajird-1300	62	12	25	25	NUM
ajird-1300	62	13	%	%	NOUN
ajird-1300	62	14	)	)	PUNCT
ajird-1300	62	15	1	1	NUM
ajird-1300	62	16	(	(	PUNCT
ajird-1300	62	17	5.9	5.9	NUM
ajird-1300	62	18	%	%	NOUN
ajird-1300	62	19	)	)	PUNCT
ajird-1300	62	20	10	10	NUM
ajird-1300	62	21	.	.	PUNCT
ajird-1300	63	1	peptic	peptic	ADJ
ajird-1300	63	2	ulcer	ulcer	NOUN
ajird-1300	63	3	of	of	ADP
ajird-1300	63	4	the	the	DET
ajird-1300	63	5	12th	12th	PROPN
ajird-1300	63	6	p.c	p.c	PROPN
ajird-1300	63	7	.	.	PROPN
ajird-1300	63	8	1	1	NUM
ajird-1300	63	9	(	(	PUNCT
ajird-1300	63	10	5.9	5.9	NUM
ajird-1300	63	11	%	%	NOUN
ajird-1300	63	12	)	)	PUNCT
ajird-1300	63	13	11	11	NUM
ajird-1300	63	14	.	.	PUNCT
ajird-1300	64	1	chf	chf	NOUN
ajird-1300	64	2	1	1	NUM
ajird-1300	64	3	-	-	SYM
ajird-1300	64	4	2	2	NUM
ajird-1300	64	5	st	st	NOUN
ajird-1300	64	6	.	.	PROPN
ajird-1300	64	7	3	3	NUM
ajird-1300	64	8	(	(	PUNCT
ajird-1300	64	9	75	75	NUM
ajird-1300	64	10	%	%	NOUN
ajird-1300	64	11	)	)	PUNCT
ajird-1300	64	12	15(88.2	15(88.2	ADJ
ajird-1300	64	13	%	%	NOUN
ajird-1300	64	14	)	)	PUNCT
ajird-1300	64	15	12	12	NUM
ajird-1300	64	16	.	.	PUNCT
ajird-1300	65	1	discirculatory	discirculatory	NOUN
ajird-1300	65	2	encephalopathy	encephalopathy	ADJ
ajird-1300	65	3	1	1	NUM
ajird-1300	65	4	-	-	SYM
ajird-1300	65	5	2	2	NUM
ajird-1300	65	6	st	st	NOUN
ajird-1300	65	7	.	.	PROPN
ajird-1300	65	8	2	2	NUM
ajird-1300	65	9	(	(	PUNCT
ajird-1300	65	10	50	50	NUM
ajird-1300	65	11	%	%	NOUN
ajird-1300	65	12	)	)	PUNCT
ajird-1300	65	13	14	14	NUM
ajird-1300	65	14	(	(	PUNCT
ajird-1300	65	15	82.3	82.3	NUM
ajird-1300	65	16	%	%	NOUN
ajird-1300	65	17	)	)	PUNCT
ajird-1300	65	18	13	13	NUM
ajird-1300	65	19	.	.	PUNCT
ajird-1300	66	1	diabetic	diabetic	ADJ
ajird-1300	66	2	encephalopathy	encephalopathy	ADJ
ajird-1300	66	3	1	1	NUM
ajird-1300	66	4	-	-	SYM
ajird-1300	66	5	2	2	NUM
ajird-1300	66	6	st	st	NOUN
ajird-1300	66	7	.	.	PROPN
ajird-1300	66	8	3	3	NUM
ajird-1300	66	9	(	(	PUNCT
ajird-1300	66	10	17.6	17.6	NUM
ajird-1300	66	11	%	%	NOUN
ajird-1300	66	12	)	)	PUNCT
ajird-1300	66	13	14	14	NUM
ajird-1300	66	14	.	.	PUNCT
ajird-1300	66	15	consequence	consequence	NOUN
ajird-1300	66	16	of	of	ADP
ajird-1300	66	17	ischemic	ischemic	ADJ
ajird-1300	66	18	stroke	stroke	NOUN
ajird-1300	66	19	1	1	NUM
ajird-1300	66	20	(	(	PUNCT
ajird-1300	66	21	5.9	5.9	NUM
ajird-1300	66	22	%	%	NOUN
ajird-1300	66	23	)	)	PUNCT
ajird-1300	66	24	15	15	NUM
ajird-1300	66	25	.	.	PUNCT
ajird-1300	67	1	diabetic	diabetic	ADJ
ajird-1300	67	2	polyneuropathy	polyneuropathy	ADJ
ajird-1300	67	3	1	1	NUM
ajird-1300	67	4	(	(	PUNCT
ajird-1300	67	5	25	25	NUM
ajird-1300	67	6	%	%	NOUN
ajird-1300	67	7	)	)	PUNCT
ajird-1300	67	8	1	1	NUM
ajird-1300	67	9	(	(	PUNCT
ajird-1300	67	10	5.9	5.9	NUM
ajird-1300	67	11	%	%	NOUN
ajird-1300	67	12	)	)	PUNCT
ajird-1300	67	13	16	16	NUM
ajird-1300	67	14	.	.	PUNCT
ajird-1300	68	1	left	leave	VERB
ajird-1300	68	2	ventricular	ventricular	ADJ
ajird-1300	68	3	(	(	PUNCT
ajird-1300	68	4	lv	lv	PROPN
ajird-1300	68	5	)	)	PUNCT
ajird-1300	68	6	aneurysm	aneurysm	NOUN
ajird-1300	68	7	1	1	NUM
ajird-1300	68	8	(	(	PUNCT
ajird-1300	68	9	5.9	5.9	NUM
ajird-1300	68	10	%	%	NOUN
ajird-1300	68	11	)	)	PUNCT
ajird-1300	68	12	17	17	NUM
ajird-1300	68	13	.	.	PUNCT
ajird-1300	69	1	thrombus	thrombus	NOUN
ajird-1300	69	2	in	in	ADP
ajird-1300	69	3	the	the	DET
ajird-1300	69	4	lv	lv	PROPN
ajird-1300	69	5	cavity	cavity	NOUN
ajird-1300	69	6	1	1	NUM
ajird-1300	69	7	(	(	PUNCT
ajird-1300	69	8	5.9	5.9	NUM
ajird-1300	69	9	%	%	NOUN
ajird-1300	69	10	)	)	PUNCT
ajird-1300	69	11	18	18	NUM
ajird-1300	69	12	.	.	PUNCT
ajird-1300	69	13	chronic	chronic	ADJ
ajird-1300	69	14	renal	renal	ADJ
ajird-1300	69	15	failure	failure	NOUN
ajird-1300	69	16	2	2	NUM
ajird-1300	69	17	1	1	NUM
ajird-1300	69	18	(	(	PUNCT
ajird-1300	69	19	5.9	5.9	NUM
ajird-1300	69	20	%	%	NOUN
ajird-1300	69	21	)	)	PUNCT
ajird-1300	69	22	19	19	NUM
ajird-1300	69	23	.	.	PUNCT
ajird-1300	70	1	ventricular	ventricular	ADJ
ajird-1300	70	2	extrasystole	extrasystole	ADJ
ajird-1300	70	3	2	2	NUM
ajird-1300	70	4	(	(	PUNCT
ajird-1300	70	5	50	50	NUM
ajird-1300	70	6	%	%	NOUN
ajird-1300	70	7	)	)	PUNCT
ajird-1300	70	8	20	20	NUM
ajird-1300	70	9	.	.	PUNCT
ajird-1300	71	1	transient	transient	VERB
ajird-1300	71	2	ischemic	ischemic	ADJ
ajird-1300	71	3	attacks	attack	NOUN
ajird-1300	71	4	1	1	NUM
ajird-1300	71	5	(	(	PUNCT
ajird-1300	71	6	5.9	5.9	NUM
ajird-1300	71	7	%	%	NOUN
ajird-1300	71	8	)	)	PUNCT
ajird-1300	71	9	as	as	SCONJ
ajird-1300	71	10	can	can	AUX
ajird-1300	71	11	be	be	AUX
ajird-1300	71	12	seen	see	VERB
ajird-1300	71	13	from	from	ADP
ajird-1300	71	14	table	table	NOUN
ajird-1300	71	15	3	3	NUM
ajird-1300	71	16	,	,	PUNCT
ajird-1300	71	17	among	among	ADP
ajird-1300	71	18	the	the	DET
ajird-1300	71	19	metabolic	metabolic	NOUN
ajird-1300	71	20	disorders	disorder	NOUN
ajird-1300	71	21	in	in	ADP
ajird-1300	71	22	the	the	DET
ajird-1300	71	23	examined	examine	VERB
ajird-1300	71	24	patients	patient	NOUN
ajird-1300	71	25	there	there	PRON
ajird-1300	71	26	were	be	VERB
ajird-1300	71	27	such	such	ADJ
ajird-1300	71	28	as	as	ADP
ajird-1300	71	29	obesity	obesity	NOUN
ajird-1300	71	30	of	of	ADP
ajird-1300	71	31	1	1	NUM
ajird-1300	71	32	-	-	SYM
ajird-1300	71	33	2	2	NUM
ajird-1300	71	34	degrees	degree	NOUN
ajird-1300	71	35	in	in	ADP
ajird-1300	71	36	20	20	NUM
ajird-1300	71	37	patients	patient	NOUN
ajird-1300	71	38	out	out	ADP
ajird-1300	71	39	of	of	ADP
ajird-1300	71	40	the	the	DET
ajird-1300	71	41	total	total	ADJ
ajird-1300	71	42	number	number	NOUN
ajird-1300	71	43	of	of	ADP
ajird-1300	71	44	patients	patient	NOUN
ajird-1300	71	45	(	(	PUNCT
ajird-1300	71	46	95.2	95.2	NUM
ajird-1300	71	47	%	%	NOUN
ajird-1300	71	48	)	)	PUNCT
ajird-1300	71	49	,	,	PUNCT
ajird-1300	71	50	diabetes	diabetes	NOUN
ajird-1300	71	51	mellitus	mellitus	NOUN
ajird-1300	71	52	type	type	VERB
ajird-1300	71	53	2	2	NUM
ajird-1300	71	54	in	in	ADP
ajird-1300	71	55	7	7	NUM
ajird-1300	71	56	(	(	PUNCT
ajird-1300	71	57	33.3	33.3	NUM
ajird-1300	71	58	%	%	NOUN
ajird-1300	71	59	)	)	PUNCT
ajird-1300	71	60	,	,	PUNCT
ajird-1300	71	61	etc	etc	X
ajird-1300	71	62	.	.	X
ajird-1300	72	1	among	among	ADP
ajird-1300	72	2	the	the	DET
ajird-1300	72	3	complications	complication	NOUN
ajird-1300	72	4	of	of	ADP
ajird-1300	72	5	the	the	DET
ajird-1300	72	6	underlying	underlie	VERB
ajird-1300	72	7	disease	disease	NOUN
ajird-1300	72	8	,	,	PUNCT
ajird-1300	72	9	the	the	DET
ajird-1300	72	10	following	following	NOUN
ajird-1300	72	11	dominated	dominate	VERB
ajird-1300	72	12	:	:	PUNCT
ajird-1300	72	13	chronic	chronic	ADJ
ajird-1300	72	14	heart	heart	NOUN
ajird-1300	72	15	failure	failure	NOUN
ajird-1300	72	16	(	(	PUNCT
ajird-1300	72	17	chf	chf	NOUN
ajird-1300	72	18	)	)	PUNCT
ajird-1300	72	19	1	1	NUM
ajird-1300	72	20	-	-	SYM
ajird-1300	72	21	2	2	NUM
ajird-1300	72	22	st	st	NOUN
ajird-1300	72	23	in	in	ADP
ajird-1300	72	24	18	18	NUM
ajird-1300	72	25	patients	patient	NOUN
ajird-1300	72	26	out	out	ADP
ajird-1300	72	27	of	of	ADP
ajird-1300	72	28	21	21	NUM
ajird-1300	72	29	(	(	PUNCT
ajird-1300	72	30	85.7	85.7	NUM
ajird-1300	72	31	%	%	NOUN
ajird-1300	72	32	)	)	PUNCT
ajird-1300	72	33	,	,	PUNCT
ajird-1300	72	34	as	as	ADV
ajird-1300	72	35	well	well	ADV
ajird-1300	72	36	as	as	ADP
ajird-1300	72	37	discirculatory	discirculatory	NOUN
ajird-1300	72	38	encephalopathy	encephalopathy	NOUN
ajird-1300	72	39	in	in	ADP
ajird-1300	72	40	16	16	NUM
ajird-1300	72	41	(	(	PUNCT
ajird-1300	72	42	76.2	76.2	NUM
ajird-1300	72	43	%	%	NOUN
ajird-1300	72	44	)	)	PUNCT
ajird-1300	72	45	.	.	PUNCT
ajird-1300	73	1	among	among	ADP
ajird-1300	73	2	the	the	DET
ajird-1300	73	3	concomitant	concomitant	ADJ
ajird-1300	73	4	diseases	disease	NOUN
ajird-1300	73	5	,	,	PUNCT
ajird-1300	73	6	the	the	DET
ajird-1300	73	7	most	most	ADV
ajird-1300	73	8	common	common	ADJ
ajird-1300	73	9	were	be	AUX
ajird-1300	73	10	hypertension	hypertension	NOUN
ajird-1300	73	11	in	in	ADP
ajird-1300	73	12	18	18	NUM
ajird-1300	73	13	(	(	PUNCT
ajird-1300	73	14	85.7	85.7	NUM
ajird-1300	73	15	%	%	NOUN
ajird-1300	73	16	)	)	PUNCT
ajird-1300	73	17	,	,	PUNCT
ajird-1300	73	18	widespread	widespread	ADJ
ajird-1300	73	19	osteochondrosis	osteochondrosis	NOUN
ajird-1300	73	20	of	of	ADP
ajird-1300	73	21	the	the	DET
ajird-1300	73	22	spine	spine	NOUN
ajird-1300	73	23	in	in	ADP
ajird-1300	73	24	7	7	NUM
ajird-1300	73	25	(	(	PUNCT
ajird-1300	73	26	33.3	33.3	NUM
ajird-1300	73	27	%	%	NOUN
ajird-1300	73	28	)	)	PUNCT
ajird-1300	73	29	.	.	PUNCT
ajird-1300	74	1	the	the	DET
ajird-1300	74	2	study	study	NOUN
ajird-1300	74	3	of	of	ADP
ajird-1300	74	4	the	the	DET
ajird-1300	74	5	objective	objective	ADJ
ajird-1300	74	6	status	status	NOUN
ajird-1300	74	7	of	of	ADP
ajird-1300	74	8	patients	patient	NOUN
ajird-1300	74	9	showed	show	VERB
ajird-1300	74	10	the	the	DET
ajird-1300	74	11	following	follow	VERB
ajird-1300	74	12	changes	change	NOUN
ajird-1300	74	13	in	in	ADP
ajird-1300	74	14	anthropometric	anthropometric	ADJ
ajird-1300	74	15	indicators	indicator	NOUN
ajird-1300	74	16	,	,	PUNCT
ajird-1300	74	17	which	which	PRON
ajird-1300	74	18	are	be	AUX
ajird-1300	74	19	shown	show	VERB
ajird-1300	74	20	in	in	ADP
ajird-1300	74	21	table	table	NOUN
ajird-1300	74	22	4	4	NUM
ajird-1300	74	23	.	.	PUNCT
ajird-1300	74	24	american	american	PROPN
ajird-1300	74	25	journal	journal	PROPN
ajird-1300	74	26	of	of	ADP
ajird-1300	74	27	interdisciplinary	interdisciplinary	ADJ
ajird-1300	74	28	research	research	NOUN
ajird-1300	74	29	and	and	CCONJ
ajird-1300	74	30	development	development	NOUN
ajird-1300	74	31	issn	issn	PROPN
ajird-1300	74	32	online	online	NOUN
ajird-1300	74	33	:	:	PUNCT
ajird-1300	74	34	2771	2771	NUM
ajird-1300	74	35	-	-	SYM
ajird-1300	74	36	8948	8948	NUM
ajird-1300	74	37	website	website	NOUN
ajird-1300	74	38	:	:	PUNCT
ajird-1300	74	39	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-1300	74	40	volume	volume	NOUN
ajird-1300	74	41	33	33	NUM
ajird-1300	74	42	,	,	PUNCT
ajird-1300	74	43	october	october	PROPN
ajird-1300	74	44	2024	2024	NUM
ajird-1300	74	45	10	10	NUM
ajird-1300	74	46	|	|	ADV
ajird-1300	74	47	p	p	X
ajird-1300	74	48	a	a	DET
ajird-1300	74	49	g	g	NOUN
ajird-1300	74	50	e	e	NOUN
ajird-1300	74	51	table	table	NOUN
ajird-1300	74	52	4	4	NUM
ajird-1300	74	53	.	.	PUNCT
ajird-1300	74	54	average	average	ADJ
ajird-1300	74	55	values	value	NOUN
ajird-1300	74	56	of	of	ADP
ajird-1300	74	57	anthropometric	anthropometric	ADJ
ajird-1300	74	58	indicators	indicator	NOUN
ajird-1300	74	59	of	of	ADP
ajird-1300	74	60	patients	patient	NOUN
ajird-1300	74	61	.	.	PUNCT
ajird-1300	75	1	n	n	CCONJ
ajird-1300	75	2	o.	o.	ADJ
ajird-1300	75	3	indicato	indicato	ADJ
ajird-1300	75	4	rs	rs	NOUN
ajird-1300	75	5	norm	norm	NOUN
ajird-1300	75	6	(	(	PUNCT
ajird-1300	75	7	who	who	PRON
ajird-1300	75	8	)	)	PUNCT
ajird-1300	75	9	men	man	NOUN
ajird-1300	75	10	women	woman	NOUN
ajird-1300	75	11	1	1	NUM
ajird-1300	75	12	gr	gr	NUM
ajird-1300	75	13	2	2	NUM
ajird-1300	75	14	gr	gr	NUM
ajird-1300	75	15	1	1	NUM
ajird-1300	75	16	gr	gr	NUM
ajird-1300	75	17	2	2	NUM
ajird-1300	75	18	gr	gr	NUM
ajird-1300	75	19	1	1	NUM
ajird-1300	75	20	height	height	NOUN
ajird-1300	75	21	standing	standing	NOUN
ajird-1300	75	22	,	,	PUNCT
ajird-1300	75	23	cm	cm	NOUN
ajird-1300	75	24	m	m	VERB
ajird-1300	75	25	up	up	ADP
ajird-1300	75	26	to	to	ADP
ajird-1300	75	27	174.7	174.7	NUM
ajird-1300	75	28	w	w	NOUN
ajird-1300	75	29	up	up	ADP
ajird-1300	75	30	to	to	ADP
ajird-1300	75	31	162.2	162.2	NUM
ajird-1300	75	32	175.2	175.2	NUM
ajird-1300	75	33	±	±	NUM
ajird-1300	75	34	9.5	9.5	NUM
ajird-1300	75	35	170.2±8.3	170.2±8.3	NUM
ajird-1300	75	36	155.5	155.5	NUM
ajird-1300	75	37	±	±	NUM
ajird-1300	75	38	3.7	3.7	NUM
ajird-1300	75	39	156.2±3.5	156.2±3.5	NUM
ajird-1300	75	40	2	2	NUM
ajird-1300	75	41	weight	weight	NOUN
ajird-1300	75	42	,	,	PUNCT
ajird-1300	75	43	kg	kg	INTJ
ajird-1300	75	44	m	m	VERB
ajird-1300	75	45	not	not	PART
ajird-1300	75	46	<	<	X
ajird-1300	76	1	60	60	NUM
ajird-1300	76	2	f	f	X
ajird-1300	76	3	not	not	PART
ajird-1300	76	4	<	<	X
ajird-1300	76	5	55	55	NUM
ajird-1300	76	6	86.5	86.5	NUM
ajird-1300	76	7	±	±	NUM
ajird-1300	76	8	3.6	3.6	NUM
ajird-1300	76	9	97.9	97.9	NUM
ajird-1300	76	10	±	±	NUM
ajird-1300	76	11	4.1	4.1	NUM
ajird-1300	76	12	82.5	82.5	NUM
ajird-1300	76	13	±	±	NUM
ajird-1300	76	14	2.5	2.5	NUM
ajird-1300	76	15	79.16	79.16	NUM
ajird-1300	76	16	±	±	NOUN
ajird-1300	76	17	6.3	6.3	NUM
ajird-1300	76	18	3	3	NUM
ajird-1300	76	19	waist	waist	NOUN
ajird-1300	76	20	size	size	NOUN
ajird-1300	76	21	(	(	PUNCT
ajird-1300	76	22	cm	cm	NOUN
ajird-1300	76	23	)	)	PUNCT
ajird-1300	76	24	m	m	PROPN
ajird-1300	76	25	to	to	ADP
ajird-1300	76	26	94	94	NUM
ajird-1300	76	27	f	f	NOUN
ajird-1300	76	28	up	up	ADP
ajird-1300	76	29	to	to	PART
ajird-1300	76	30	80	80	NUM
ajird-1300	76	31	104.5	104.5	NUM
ajird-1300	76	32	±	±	NUM
ajird-1300	76	33	8.7	8.7	NUM
ajird-1300	76	34	112.63	112.63	NUM
ajird-1300	76	35	±	±	NUM
ajird-1300	76	36	8.5	8.5	NUM
ajird-1300	76	37	99.2	99.2	NUM
ajird-1300	76	38	±	±	NUM
ajird-1300	76	39	3.3	3.3	NUM
ajird-1300	76	40	110.83	110.83	NUM
ajird-1300	76	41	±9.1	±9.1	PROPN
ajird-1300	76	42	4	4	NUM
ajird-1300	76	43	hip	hip	NOUN
ajird-1300	76	44	volume	volume	NOUN
ajird-1300	76	45	(	(	PUNCT
ajird-1300	76	46	cm	cm	NOUN
ajird-1300	76	47	)	)	PUNCT
ajird-1300	77	1	m	m	PROPN
ajird-1300	77	2	to	to	ADP
ajird-1300	77	3	94	94	NUM
ajird-1300	77	4	f	f	NOUN
ajird-1300	77	5	up	up	ADP
ajird-1300	77	6	to	to	PART
ajird-1300	77	7	90	90	NUM
ajird-1300	77	8	103.5	103.5	NUM
ajird-1300	77	9	±	±	NUM
ajird-1300	77	10	8.4	8.4	NUM
ajird-1300	77	11	111.81±9.1	111.81±9.1	NUM
ajird-1300	77	12	112.5	112.5	NUM
ajird-1300	77	13	±	±	NUM
ajird-1300	77	14	8.9	8.9	NUM
ajird-1300	77	15	118.16	118.16	NUM
ajird-1300	77	16	±8.5	±8.5	PROPN
ajird-1300	77	17	5	5	NUM
ajird-1300	77	18	ot	ot	NOUN
ajird-1300	77	19	/	/	SYM
ajird-1300	77	20	ob	ob	NOUN
ajird-1300	77	21	m	m	NOUN
ajird-1300	77	22	=	=	SYM
ajird-1300	77	23	1	1	NUM
ajird-1300	77	24	w	w	NOUN
ajird-1300	77	25	up	up	ADP
ajird-1300	77	26	to	to	PART
ajird-1300	77	27	0.8	0.8	NUM
ajird-1300	77	28	1.00	1.00	NUM
ajird-1300	77	29	±	±	NUM
ajird-1300	77	30	0.02	0.02	NUM
ajird-1300	77	31	1.00	1.00	NUM
ajird-1300	77	32	±	±	NUM
ajird-1300	77	33	0.02	0.02	NUM
ajird-1300	77	34	0.85	0.85	NUM
ajird-1300	77	35	±	±	NUM
ajird-1300	77	36	0.04	0.04	NUM
ajird-1300	77	37	0.93	0.93	NUM
ajird-1300	77	38	±	±	NUM
ajird-1300	77	39	0.05	0.05	NUM
ajird-1300	77	40	6	6	NUM
ajird-1300	77	41	bmi	bmi	NOUN
ajird-1300	77	42	,	,	PUNCT
ajird-1300	77	43	kg	kg	PROPN
ajird-1300	77	44	/	/	SYM
ajird-1300	77	45	m2	m2	PROPN
ajird-1300	77	46	18.524.9	18.524.9	NUM
ajird-1300	77	47	28.2	28.2	NUM
ajird-1300	77	48	±	±	NUM
ajird-1300	77	49	3.6	3.6	NUM
ajird-1300	77	50	33.87	33.87	NUM
ajird-1300	77	51	±	±	NUM
ajird-1300	77	52	4.4	4.4	NUM
ajird-1300	77	53	34.4	34.4	NUM
ajird-1300	77	54	±	±	NUM
ajird-1300	77	55	2.5	2.5	NUM
ajird-1300	77	56	32.57	32.57	NUM
ajird-1300	77	57	±	±	NUM
ajird-1300	77	58	2.7	2.7	NUM
ajird-1300	77	59	*	*	NOUN
ajird-1300	77	60	data	datum	NOUN
ajird-1300	77	61	for	for	ADP
ajird-1300	77	62	height	height	NOUN
ajird-1300	77	63	and	and	CCONJ
ajird-1300	77	64	weight	weight	NOUN
ajird-1300	77	65	are	be	AUX
ajird-1300	77	66	taken	take	VERB
ajird-1300	77	67	from	from	ADP
ajird-1300	77	68	i.i	i.i	PROPN
ajird-1300	77	69	.	.	PROPN
ajird-1300	77	70	dedov	dedov	PROPN
ajird-1300	77	71	“	"	PUNCT
ajird-1300	77	72	somatotropic	somatotropic	NOUN
ajird-1300	77	73	insufficiency	insufficiency	NOUN
ajird-1300	77	74	”	"	PUNCT
ajird-1300	77	75	,	,	PUNCT
ajird-1300	77	76	moscow	moscow	PROPN
ajird-1300	77	77	,	,	PUNCT
ajird-1300	77	78	1998	1998	NUM
ajird-1300	77	79	,	,	PUNCT
ajird-1300	77	80	302	302	NUM
ajird-1300	77	81	p.	p.	NOUN
ajird-1300	77	82	according	accord	VERB
ajird-1300	77	83	to	to	ADP
ajird-1300	77	84	the	the	DET
ajird-1300	77	85	analysis	analysis	NOUN
ajird-1300	77	86	of	of	ADP
ajird-1300	77	87	average	average	ADJ
ajird-1300	77	88	values	value	NOUN
ajird-1300	77	89	of	of	ADP
ajird-1300	77	90	anthropometric	anthropometric	ADJ
ajird-1300	77	91	parameters	parameter	NOUN
ajird-1300	77	92	,	,	PUNCT
ajird-1300	77	93	men	man	NOUN
ajird-1300	77	94	of	of	ADP
ajird-1300	77	95	group	group	NOUN
ajird-1300	77	96	1	1	NUM
ajird-1300	77	97	had	have	VERB
ajird-1300	77	98	pre	pre	ADJ
ajird-1300	77	99	-	-	NOUN
ajird-1300	77	100	obesity	obesity	ADJ
ajird-1300	77	101	bmi	bmi	NOUN
ajird-1300	77	102	within	within	ADP
ajird-1300	77	103	28.2	28.2	NUM
ajird-1300	77	104	kg	kg	NOUN
ajird-1300	77	105	/	/	SYM
ajird-1300	77	106	m2	m2	PROPN
ajird-1300	77	107	,	,	PUNCT
ajird-1300	77	108	women	woman	NOUN
ajird-1300	77	109	of	of	ADP
ajird-1300	77	110	group	group	NOUN
ajird-1300	77	111	1	1	NUM
ajird-1300	77	112	had	have	VERB
ajird-1300	77	113	grade	grade	NOUN
ajird-1300	77	114	1	1	NUM
ajird-1300	77	115	obesity	obesity	NOUN
ajird-1300	77	116	bmi	bmi	NOUN
ajird-1300	77	117	=	=	PUNCT
ajird-1300	77	118	34.4	34.4	NUM
ajird-1300	77	119	,	,	PUNCT
ajird-1300	77	120	and	and	CCONJ
ajird-1300	77	121	both	both	DET
ajird-1300	77	122	men	man	NOUN
ajird-1300	77	123	and	and	CCONJ
ajird-1300	77	124	women	woman	NOUN
ajird-1300	77	125	had	have	VERB
ajird-1300	77	126	grade	grade	NOUN
ajird-1300	77	127	1	1	NUM
ajird-1300	77	128	obesity	obesity	NOUN
ajird-1300	77	129	(	(	PUNCT
ajird-1300	77	130	respectively	respectively	ADV
ajird-1300	77	131	,	,	PUNCT
ajird-1300	77	132	bmi	bmi	VERB
ajird-1300	77	133	33.87/32.57	33.87/32.57	NUM
ajird-1300	77	134	kg	kg	NOUN
ajird-1300	77	135	/	/	SYM
ajird-1300	77	136	m2	m2	PROPN
ajird-1300	77	137	)	)	PUNCT
ajird-1300	77	138	,	,	PUNCT
ajird-1300	77	139	which	which	PRON
ajird-1300	77	140	increases	increase	VERB
ajird-1300	77	141	the	the	DET
ajird-1300	77	142	risk	risk	NOUN
ajird-1300	77	143	of	of	ADP
ajird-1300	77	144	concomitant	concomitant	ADJ
ajird-1300	77	145	diseases	disease	NOUN
ajird-1300	77	146	.	.	PUNCT
ajird-1300	78	1	it	it	PRON
ajird-1300	78	2	should	should	AUX
ajird-1300	78	3	be	be	AUX
ajird-1300	78	4	noted	note	VERB
ajird-1300	78	5	that	that	SCONJ
ajird-1300	78	6	wc	wc	PROPN
ajird-1300	78	7	in	in	ADP
ajird-1300	78	8	both	both	DET
ajird-1300	78	9	men	man	NOUN
ajird-1300	78	10	and	and	CCONJ
ajird-1300	78	11	women	woman	NOUN
ajird-1300	78	12	of	of	ADP
ajird-1300	78	13	both	both	DET
ajird-1300	78	14	groups	group	NOUN
ajird-1300	78	15	was	be	AUX
ajird-1300	78	16	significantly	significantly	ADV
ajird-1300	78	17	increased	increase	VERB
ajird-1300	78	18	(	(	PUNCT
ajird-1300	78	19	p	p	X
ajird-1300	78	20	<	<	X
ajird-1300	78	21	0.05	0.05	NUM
ajird-1300	78	22	)	)	PUNCT
ajird-1300	78	23	and	and	CCONJ
ajird-1300	78	24	was	be	AUX
ajird-1300	78	25	highest	high	ADJ
ajird-1300	78	26	in	in	ADP
ajird-1300	78	27	patients	patient	NOUN
ajird-1300	78	28	of	of	ADP
ajird-1300	78	29	both	both	DET
ajird-1300	78	30	sexes	sex	NOUN
ajird-1300	78	31	of	of	ADP
ajird-1300	78	32	group	group	NOUN
ajird-1300	78	33	2	2	NUM
ajird-1300	78	34	.	.	PUNCT
ajird-1300	79	1	all	all	DET
ajird-1300	79	2	this	this	PRON
ajird-1300	79	3	indicates	indicate	VERB
ajird-1300	79	4	an	an	DET
ajird-1300	79	5	increased	increased	ADJ
ajird-1300	79	6	risk	risk	NOUN
ajird-1300	79	7	of	of	ADP
ajird-1300	79	8	developing	develop	VERB
ajird-1300	79	9	metabolic	metabolic	NOUN
ajird-1300	79	10	complications	complication	NOUN
ajird-1300	79	11	in	in	ADP
ajird-1300	79	12	both	both	DET
ajird-1300	79	13	groups	group	NOUN
ajird-1300	79	14	of	of	ADP
ajird-1300	79	15	patients	patient	NOUN
ajird-1300	79	16	.	.	PUNCT
ajird-1300	80	1	next	next	ADV
ajird-1300	80	2	,	,	PUNCT
ajird-1300	80	3	we	we	PRON
ajird-1300	80	4	studied	study	VERB
ajird-1300	80	5	the	the	DET
ajird-1300	80	6	neuroendocrine	neuroendocrine	NOUN
ajird-1300	80	7	symptoms	symptom	NOUN
ajird-1300	80	8	of	of	ADP
ajird-1300	80	9	patients	patient	NOUN
ajird-1300	80	10	.	.	PUNCT
ajird-1300	81	1	in	in	ADP
ajird-1300	81	2	order	order	NOUN
ajird-1300	81	3	to	to	PART
ajird-1300	81	4	identify	identify	VERB
ajird-1300	81	5	aghd	aghd	NOUN
ajird-1300	81	6	,	,	PUNCT
ajird-1300	81	7	we	we	PRON
ajird-1300	81	8	used	use	VERB
ajird-1300	81	9	the	the	DET
ajird-1300	81	10	quality	quality	NOUN
ajird-1300	81	11	of	of	ADP
ajird-1300	81	12	life	life	NOUN
ajird-1300	81	13	for	for	ADP
ajird-1300	81	14	adult	adult	NOUN
ajird-1300	81	15	growth	growth	NOUN
ajird-1300	81	16	hormone	hormone	NOUN
ajird-1300	81	17	deficiency	deficiency	NOUN
ajird-1300	81	18	(	(	PUNCT
ajird-1300	81	19	qol	qol	NOUN
ajird-1300	81	20	aghd	aghd	PROPN
ajird-1300	81	21	)	)	PUNCT
ajird-1300	81	22	questionnaire	questionnaire	NOUN
ajird-1300	81	23	(	(	PUNCT
ajird-1300	81	24	18	18	NUM
ajird-1300	81	25	)	)	PUNCT
ajird-1300	81	26	.	.	PUNCT
ajird-1300	82	1	these	these	DET
ajird-1300	82	2	data	datum	NOUN
ajird-1300	82	3	are	be	AUX
ajird-1300	82	4	presented	present	VERB
ajird-1300	82	5	in	in	ADP
ajird-1300	82	6	table	table	NOUN
ajird-1300	82	7	5	5	NUM
ajird-1300	82	8	.	.	PUNCT
ajird-1300	82	9	table	table	NOUN
ajird-1300	82	10	5	5	NUM
ajird-1300	82	11	.	.	PUNCT
ajird-1300	82	12	results	result	NOUN
ajird-1300	82	13	of	of	ADP
ajird-1300	82	14	the	the	DET
ajird-1300	82	15	survey	survey	NOUN
ajird-1300	82	16	of	of	ADP
ajird-1300	82	17	patients	patient	NOUN
ajird-1300	82	18	using	use	VERB
ajird-1300	82	19	the	the	DET
ajird-1300	82	20	questionnaire	questionnaire	NOUN
ajird-1300	82	21	for	for	ADP
ajird-1300	82	22	the	the	DET
ajird-1300	82	23	development	development	NOUN
ajird-1300	82	24	of	of	ADP
ajird-1300	82	25	gastrointestinal	gastrointestinal	ADJ
ajird-1300	82	26	tract	tract	NOUN
ajird-1300	82	27	disease	disease	NOUN
ajird-1300	82	28	in	in	ADP
ajird-1300	82	29	adults	adult	NOUN
ajird-1300	83	1	no	no	INTJ
ajird-1300	83	2	.	.	PUNCT
ajird-1300	83	3	number	number	NOUN
ajird-1300	83	4	of	of	ADP
ajird-1300	83	5	respondents	respondent	NOUN
ajird-1300	83	6	in	in	ADP
ajird-1300	83	7	the	the	DET
ajird-1300	83	8	group	group	NOUN
ajird-1300	83	9	control	control	PROPN
ajird-1300	83	10	average	average	ADJ
ajird-1300	83	11	score	score	NOUN
ajird-1300	83	12	reliability	reliability	NOUN
ajird-1300	83	13	of	of	ADP
ajird-1300	83	14	differences	difference	NOUN
ajird-1300	83	15	,	,	PUNCT
ajird-1300	83	16	p	p	NOUN
ajird-1300	83	17	1	1	NUM
ajird-1300	83	18	1	1	NUM
ajird-1300	83	19	group	group	NOUN
ajird-1300	83	20	(	(	PUNCT
ajird-1300	83	21	n	n	NOUN
ajird-1300	83	22	=	=	SYM
ajird-1300	83	23	4	4	NUM
ajird-1300	83	24	)	)	PUNCT
ajird-1300	83	25	7.3±	7.3±	NUM
ajird-1300	83	26	0.4	0.4	NUM
ajird-1300	83	27	9.75±	9.75±	NUM
ajird-1300	83	28	0.4	0.4	NUM
ajird-1300	83	29	p	p	X
ajird-1300	83	30	>	>	X
ajird-1300	83	31	0.5	0.5	NUM
ajird-1300	83	32	2	2	NUM
ajird-1300	83	33	2	2	NUM
ajird-1300	83	34	group	group	NOUN
ajird-1300	83	35	(	(	PUNCT
ajird-1300	83	36	n=17	n=17	NOUN
ajird-1300	83	37	)	)	PUNCT
ajird-1300	83	38	17.3±	17.3±	NOUN
ajird-1300	83	39	0.3	0.3	NUM
ajird-1300	83	40	p	p	NOUN
ajird-1300	83	41	<	<	X
ajird-1300	83	42	0.05	0.05	NUM
ajird-1300	83	43	using	use	VERB
ajird-1300	83	44	the	the	DET
ajird-1300	83	45	questionnairefor	questionnairefor	NOUN
ajird-1300	83	46	the	the	DET
ajird-1300	83	47	identification	identification	NOUN
ajird-1300	83	48	of	of	ADP
ajird-1300	83	49	aghd	aghd	NOUN
ajird-1300	83	50	(	(	PUNCT
ajird-1300	83	51	qol	qol	NOUN
ajird-1300	83	52	aghd	aghd	PROPN
ajird-1300	83	53	)	)	PUNCT
ajird-1300	83	54	revealed	reveal	VERB
ajird-1300	83	55	during	during	ADP
ajird-1300	83	56	the	the	DET
ajird-1300	83	57	preliminary	preliminary	ADJ
ajird-1300	83	58	survey	survey	NOUN
ajird-1300	83	59	a	a	DET
ajird-1300	83	60	reliable	reliable	ADJ
ajird-1300	83	61	decrease	decrease	NOUN
ajird-1300	83	62	in	in	ADP
ajird-1300	83	63	scores	score	NOUN
ajird-1300	83	64	in	in	ADP
ajird-1300	83	65	15	15	NUM
ajird-1300	83	66	(	(	PUNCT
ajird-1300	83	67	71.4	71.4	NUM
ajird-1300	83	68	%	%	NOUN
ajird-1300	83	69	)	)	PUNCT
ajird-1300	83	70	patients	patient	NOUN
ajird-1300	83	71	,	,	PUNCT
ajird-1300	83	72	that	that	ADV
ajird-1300	83	73	is	is	ADV
ajird-1300	83	74	,	,	PUNCT
ajird-1300	83	75	in	in	ADP
ajird-1300	83	76	the	the	DET
ajird-1300	83	77	overwhelming	overwhelming	ADJ
ajird-1300	83	78	majority	majority	NOUN
ajird-1300	83	79	of	of	ADP
ajird-1300	83	80	patients	patient	NOUN
ajird-1300	83	81	.	.	PUNCT
ajird-1300	84	1	american	american	ADJ
ajird-1300	84	2	journal	journal	PROPN
ajird-1300	84	3	of	of	ADP
ajird-1300	84	4	interdisciplinary	interdisciplinary	ADJ
ajird-1300	84	5	research	research	NOUN
ajird-1300	84	6	and	and	CCONJ
ajird-1300	84	7	development	development	NOUN
ajird-1300	84	8	issn	issn	PROPN
ajird-1300	84	9	online	online	NOUN
ajird-1300	84	10	:	:	PUNCT
ajird-1300	84	11	2771	2771	NUM
ajird-1300	84	12	-	-	SYM
ajird-1300	84	13	8948	8948	NUM
ajird-1300	84	14	website	website	NOUN
ajird-1300	84	15	:	:	PUNCT
ajird-1300	84	16	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-1300	84	17	volume	volume	NOUN
ajird-1300	84	18	33	33	NUM
ajird-1300	84	19	,	,	PUNCT
ajird-1300	84	20	october	october	PROPN
ajird-1300	84	21	2024	2024	NUM
ajird-1300	84	22	11	11	NUM
ajird-1300	85	1	|	|	ADV
ajird-1300	85	2	p	p	NOUN
ajird-1300	85	3	a	a	DET
ajird-1300	85	4	g	g	NOUN
ajird-1300	85	5	e	e	NOUN
ajird-1300	85	6	as	as	SCONJ
ajird-1300	85	7	can	can	AUX
ajird-1300	85	8	be	be	AUX
ajird-1300	85	9	seen	see	VERB
ajird-1300	85	10	from	from	ADP
ajird-1300	85	11	table	table	NOUN
ajird-1300	85	12	5	5	NUM
ajird-1300	85	13	,	,	PUNCT
ajird-1300	85	14	the	the	DET
ajird-1300	85	15	study	study	NOUN
ajird-1300	85	16	of	of	ADP
ajird-1300	85	17	quality	quality	NOUN
ajird-1300	85	18	of	of	ADP
ajird-1300	85	19	life	life	NOUN
ajird-1300	85	20	using	use	VERB
ajird-1300	85	21	the	the	DET
ajird-1300	85	22	ghrd	ghrd	PROPN
ajird-1300	85	23	questionnaire	questionnaire	NOUN
ajird-1300	85	24	revealed	reveal	VERB
ajird-1300	85	25	its	its	PRON
ajird-1300	85	26	impairment	impairment	NOUN
ajird-1300	85	27	in	in	ADP
ajird-1300	85	28	both	both	DET
ajird-1300	85	29	groups	group	NOUN
ajird-1300	85	30	of	of	ADP
ajird-1300	85	31	patients	patient	NOUN
ajird-1300	85	32	,	,	PUNCT
ajird-1300	85	33	which	which	PRON
ajird-1300	85	34	indicates	indicate	VERB
ajird-1300	85	35	an	an	DET
ajird-1300	85	36	increased	increase	VERB
ajird-1300	85	37	likelihood	likelihood	NOUN
ajird-1300	85	38	of	of	ADP
ajird-1300	85	39	growth	growth	NOUN
ajird-1300	85	40	hormone	hormone	NOUN
ajird-1300	85	41	deficiency	deficiency	NOUN
ajird-1300	85	42	in	in	ADP
ajird-1300	85	43	both	both	DET
ajird-1300	85	44	groups	group	NOUN
ajird-1300	85	45	of	of	ADP
ajird-1300	85	46	patients	patient	NOUN
ajird-1300	85	47	.	.	PUNCT
ajird-1300	86	1	the	the	DET
ajird-1300	86	2	study	study	NOUN
ajird-1300	86	3	of	of	ADP
ajird-1300	86	4	hormonal	hormonal	ADJ
ajird-1300	86	5	status	status	NOUN
ajird-1300	86	6	revealed	reveal	VERB
ajird-1300	86	7	significant	significant	ADJ
ajird-1300	86	8	disturbances	disturbance	NOUN
ajird-1300	86	9	in	in	ADP
ajird-1300	86	10	the	the	DET
ajird-1300	86	11	concentration	concentration	NOUN
ajird-1300	86	12	of	of	ADP
ajird-1300	86	13	growth	growth	NOUN
ajird-1300	86	14	hormone	hormone	NOUN
ajird-1300	86	15	(	(	PUNCT
ajird-1300	86	16	gh	gh	PROPN
ajird-1300	86	17	)	)	PUNCT
ajird-1300	86	18	and	and	CCONJ
ajird-1300	86	19	insulin	insulin	NOUN
ajird-1300	86	20	-	-	PUNCT
ajird-1300	86	21	like	like	ADJ
ajird-1300	86	22	growth	growth	NOUN
ajird-1300	86	23	factor-1	factor-1	PROPN
ajird-1300	86	24	(	(	PUNCT
ajird-1300	86	25	igf-1	igf-1	NOUN
ajird-1300	86	26	)	)	PUNCT
ajird-1300	86	27	in	in	ADP
ajird-1300	86	28	blood	blood	NOUN
ajird-1300	86	29	plasma	plasma	NOUN
ajird-1300	86	30	,	,	PUNCT
ajird-1300	86	31	presented	present	VERB
ajird-1300	86	32	in	in	ADP
ajird-1300	86	33	table	table	NOUN
ajird-1300	86	34	6	6	NUM
ajird-1300	86	35	.	.	PUNCT
ajird-1300	86	36	table	table	NOUN
ajird-1300	86	37	6	6	NUM
ajird-1300	86	38	.	.	PUNCT
ajird-1300	87	1	average	average	ADJ
ajird-1300	87	2	gr	gr	ADP
ajird-1300	87	3	valuesand	valuesand	NOUN
ajird-1300	87	4	igf-1	igf-1	X
ajird-1300	87	5	in	in	ADP
ajird-1300	87	6	patient	patient	ADJ
ajird-1300	87	7	groups	group	NOUN
ajird-1300	87	8	no	no	INTJ
ajird-1300	87	9	.	.	PUNCT
ajird-1300	88	1	hormones	hormone	NOUN
ajird-1300	88	2	control	control	PROPN
ajird-1300	88	3	group	group	PROPN
ajird-1300	88	4	i	i	PROPN
ajird-1300	88	5	n=4	n=4	PROPN
ajird-1300	88	6	r	r	PROPN
ajird-1300	88	7	ii	ii	PROPN
ajird-1300	88	8	group	group	NOUN
ajird-1300	88	9	n=17	n=17	NOUN
ajird-1300	88	10	r	r	NOUN
ajird-1300	88	11	1	1	NUM
ajird-1300	88	12	grng	grng	NOUN
ajird-1300	88	13	/	/	SYM
ajird-1300	88	14	ml	ml	PROPN
ajird-1300	88	15	3.5	3.5	NUM
ajird-1300	88	16	±	±	NUM
ajird-1300	88	17	0.3	0.3	NUM
ajird-1300	88	18	1,1±	1,1±	NUM
ajird-1300	88	19	0.2	0.2	NUM
ajird-1300	88	20	<	<	NOUN
ajird-1300	88	21	0.05	0.05	NUM
ajird-1300	88	22	0.2±	0.2±	NUM
ajird-1300	88	23	0.01	0.01	NUM
ajird-1300	88	24	<	<	X
ajird-1300	88	25	0.05	0.05	NUM
ajird-1300	88	26	2	2	NUM
ajird-1300	88	27	igf-1,ng	igf-1,ng	PROPN
ajird-1300	88	28	/	/	SYM
ajird-1300	88	29	ml	ml	PROPN
ajird-1300	88	30	485	485	NUM
ajird-1300	88	31	±	±	NUM
ajird-1300	88	32	9.8	9.8	NUM
ajird-1300	88	33	156.3±	156.3±	NUM
ajird-1300	88	34	3.3	3.3	NUM
ajird-1300	88	35	>	>	SYM
ajird-1300	88	36	0.5	0.5	NUM
ajird-1300	88	37	129.7±	129.7±	NUM
ajird-1300	88	38	7.5	7.5	NUM
ajird-1300	88	39	<	<	NOUN
ajird-1300	88	40	0.05	0.05	NUM
ajird-1300	88	41	p	p	NOUN
ajird-1300	88	42	–	–	PUNCT
ajird-1300	88	43	reliability	reliability	NOUN
ajird-1300	88	44	of	of	ADP
ajird-1300	88	45	differences	difference	NOUN
ajird-1300	88	46	compared	compare	VERB
ajird-1300	88	47	to	to	ADP
ajird-1300	88	48	the	the	DET
ajird-1300	88	49	norm	norm	NOUN
ajird-1300	88	50	it	it	PRON
ajird-1300	88	51	was	be	AUX
ajird-1300	88	52	found	find	VERB
ajird-1300	88	53	that	that	SCONJ
ajird-1300	88	54	the	the	DET
ajird-1300	88	55	frequency	frequency	NOUN
ajird-1300	88	56	of	of	ADP
ajird-1300	88	57	ghd	ghd	NOUN
ajird-1300	88	58	in	in	ADP
ajird-1300	88	59	the	the	DET
ajird-1300	88	60	examined	examine	VERB
ajird-1300	88	61	patients	patient	NOUN
ajird-1300	88	62	with	with	ADP
ajird-1300	88	63	coronary	coronary	ADJ
ajird-1300	88	64	heart	heart	NOUN
ajird-1300	88	65	disease	disease	NOUN
ajird-1300	88	66	of	of	ADP
ajird-1300	88	67	both	both	DET
ajird-1300	88	68	groups	group	NOUN
ajird-1300	88	69	was	be	AUX
ajird-1300	88	70	15	15	NUM
ajird-1300	88	71	cases	case	NOUN
ajird-1300	88	72	out	out	ADP
ajird-1300	88	73	of	of	ADP
ajird-1300	88	74	21	21	NUM
ajird-1300	88	75	(	(	PUNCT
ajird-1300	88	76	71.4	71.4	NUM
ajird-1300	88	77	%	%	NOUN
ajird-1300	88	78	)	)	PUNCT
ajird-1300	88	79	.	.	PUNCT
ajird-1300	89	1	at	at	ADP
ajird-1300	89	2	the	the	DET
ajird-1300	89	3	same	same	ADJ
ajird-1300	89	4	time	time	NOUN
ajird-1300	89	5	,	,	PUNCT
ajird-1300	89	6	8	8	NUM
ajird-1300	89	7	(	(	PUNCT
ajird-1300	89	8	53.3	53.3	NUM
ajird-1300	89	9	%	%	NOUN
ajird-1300	89	10	)	)	PUNCT
ajird-1300	89	11	patients	patient	NOUN
ajird-1300	89	12	with	with	ADP
ajird-1300	89	13	laboratory	laboratory	NOUN
ajird-1300	89	14	-	-	PUNCT
ajird-1300	89	15	established	establish	VERB
ajird-1300	89	16	ghd	ghd	NOUN
ajird-1300	89	17	showed	show	VERB
ajird-1300	89	18	a	a	DET
ajird-1300	89	19	reliable	reliable	ADJ
ajird-1300	89	20	decrease	decrease	NOUN
ajird-1300	89	21	in	in	ADP
ajird-1300	89	22	the	the	DET
ajird-1300	89	23	concentration	concentration	NOUN
ajird-1300	89	24	of	of	ADP
ajird-1300	89	25	igf-1	igf-1	NOUN
ajird-1300	89	26	in	in	ADP
ajird-1300	89	27	the	the	DET
ajird-1300	89	28	blood	blood	NOUN
ajird-1300	89	29	plasma	plasma	NOUN
ajird-1300	89	30	.	.	PUNCT
ajird-1300	90	1	it	it	PRON
ajird-1300	90	2	should	should	AUX
ajird-1300	90	3	be	be	AUX
ajird-1300	90	4	emphasized	emphasize	VERB
ajird-1300	90	5	that	that	SCONJ
ajird-1300	90	6	gh	gh	PROPN
ajird-1300	90	7	levels	level	NOUN
ajird-1300	90	8	fluctuated	fluctuate	VERB
ajird-1300	90	9	within	within	ADP
ajird-1300	90	10	the	the	DET
ajird-1300	90	11	range	range	NOUN
ajird-1300	90	12	from	from	ADP
ajird-1300	90	13	0.15ng	0.15ng	NOUN
ajird-1300	90	14	/	/	SYM
ajird-1300	90	15	mlup	mlup	NOUN
ajird-1300	90	16	to	to	ADP
ajird-1300	90	17	0.53ng	0.53ng	NUM
ajird-1300	90	18	/	/	SYM
ajird-1300	90	19	mlin	mlin	NOUN
ajird-1300	90	20	13	13	NUM
ajird-1300	90	21	(	(	PUNCT
ajird-1300	90	22	86.6	86.6	NUM
ajird-1300	90	23	%	%	NOUN
ajird-1300	90	24	)	)	PUNCT
ajird-1300	90	25	of	of	ADP
ajird-1300	90	26	15	15	NUM
ajird-1300	90	27	patients	patient	NOUN
ajird-1300	90	28	overall	overall	ADV
ajird-1300	90	29	,	,	PUNCT
ajird-1300	90	30	indicating	indicate	VERB
ajird-1300	90	31	a	a	DET
ajird-1300	90	32	predominance	predominance	NOUN
ajird-1300	90	33	of	of	ADP
ajird-1300	90	34	low	low	ADJ
ajird-1300	90	35	basal	basal	NOUN
ajird-1300	90	36	gh	gh	PROPN
ajird-1300	90	37	concentrations	concentration	NOUN
ajird-1300	90	38	.	.	PUNCT
ajird-1300	91	1	and	and	CCONJ
ajird-1300	91	2	igf-1	igf-1	NOUN
ajird-1300	91	3	levels	level	NOUN
ajird-1300	91	4	were	be	AUX
ajird-1300	91	5	within	within	ADP
ajird-1300	91	6	58ng	58ng	NOUN
ajird-1300	91	7	/	/	SYM
ajird-1300	91	8	mlup	mlup	NOUN
ajird-1300	91	9	to	to	ADP
ajird-1300	91	10	120ng	120ng	PROPN
ajird-1300	91	11	/	/	SYM
ajird-1300	92	1	ml	ml	PROPN
ajird-1300	92	2	in	in	ADP
ajird-1300	92	3	10	10	NUM
ajird-1300	92	4	(	(	PUNCT
ajird-1300	92	5	50	50	NUM
ajird-1300	92	6	%	%	NOUN
ajird-1300	92	7	)	)	PUNCT
ajird-1300	92	8	of	of	ADP
ajird-1300	92	9	20	20	NUM
ajird-1300	92	10	patients	patient	NOUN
ajird-1300	92	11	.	.	PUNCT
ajird-1300	93	1	thus	thus	ADV
ajird-1300	93	2	,	,	PUNCT
ajird-1300	93	3	reliable	reliable	ADJ
ajird-1300	93	4	differences	difference	NOUN
ajird-1300	93	5	in	in	ADP
ajird-1300	93	6	the	the	DET
ajird-1300	93	7	average	average	ADJ
ajird-1300	93	8	concentration	concentration	NOUN
ajird-1300	93	9	and	and	CCONJ
ajird-1300	93	10	gh	gh	PROPN
ajird-1300	93	11	compared	compare	VERB
ajird-1300	93	12	to	to	ADP
ajird-1300	93	13	the	the	DET
ajird-1300	93	14	norm	norm	NOUN
ajird-1300	93	15	were	be	AUX
ajird-1300	93	16	found	find	VERB
ajird-1300	93	17	in	in	ADP
ajird-1300	93	18	both	both	DET
ajird-1300	93	19	groups	group	NOUN
ajird-1300	93	20	,	,	PUNCT
ajird-1300	93	21	especially	especially	ADV
ajird-1300	93	22	in	in	ADP
ajird-1300	93	23	the	the	DET
ajird-1300	93	24	2nd	2nd	NOUN
ajird-1300	93	25	.	.	PUNCT
ajird-1300	94	1	at	at	ADP
ajird-1300	94	2	the	the	DET
ajird-1300	94	3	same	same	ADJ
ajird-1300	94	4	time	time	NOUN
ajird-1300	94	5	,	,	PUNCT
ajird-1300	94	6	a	a	DET
ajird-1300	94	7	reliable	reliable	ADJ
ajird-1300	94	8	decrease	decrease	NOUN
ajird-1300	94	9	in	in	ADP
ajird-1300	94	10	the	the	DET
ajird-1300	94	11	average	average	ADJ
ajird-1300	94	12	values	value	NOUN
ajird-1300	94	13	of	of	ADP
ajird-1300	94	14	igf-1	igf-1	NOUN
ajird-1300	94	15	in	in	ADP
ajird-1300	94	16	blood	blood	NOUN
ajird-1300	94	17	plasma	plasma	NOUN
ajird-1300	94	18	was	be	AUX
ajird-1300	94	19	found	find	VERB
ajird-1300	94	20	only	only	ADV
ajird-1300	94	21	in	in	ADP
ajird-1300	94	22	the	the	DET
ajird-1300	94	23	2nd	2nd	ADJ
ajird-1300	94	24	group	group	NOUN
ajird-1300	94	25	of	of	ADP
ajird-1300	94	26	patients	patient	NOUN
ajird-1300	94	27	.	.	PUNCT
ajird-1300	95	1	as	as	SCONJ
ajird-1300	95	2	is	be	AUX
ajird-1300	95	3	known	know	VERB
ajird-1300	95	4	,	,	PUNCT
ajird-1300	95	5	the	the	DET
ajird-1300	95	6	content	content	NOUN
ajird-1300	95	7	of	of	ADP
ajird-1300	95	8	igf-1	igf-1	NOUN
ajird-1300	95	9	,	,	PUNCT
ajird-1300	95	10	namely	namely	ADV
ajird-1300	95	11	a	a	DET
ajird-1300	95	12	decrease	decrease	NOUN
ajird-1300	95	13	in	in	ADP
ajird-1300	95	14	its	its	PRON
ajird-1300	95	15	level	level	NOUN
ajird-1300	95	16	from	from	ADP
ajird-1300	95	17	normal	normal	ADJ
ajird-1300	95	18	values	value	NOUN
ajird-1300	95	19	,	,	PUNCT
ajird-1300	95	20	is	be	AUX
ajird-1300	95	21	a	a	DET
ajird-1300	95	22	marker	marker	NOUN
ajird-1300	95	23	of	of	ADP
ajird-1300	95	24	ghd	ghd	NOUN
ajird-1300	95	25	in	in	ADP
ajird-1300	95	26	adults	adult	NOUN
ajird-1300	95	27	.	.	PUNCT
ajird-1300	96	1	therefore	therefore	ADV
ajird-1300	96	2	,	,	PUNCT
ajird-1300	96	3	ghd	ghd	NOUN
ajird-1300	96	4	in	in	ADP
ajird-1300	96	5	adults	adult	NOUN
ajird-1300	96	6	was	be	AUX
ajird-1300	96	7	most	most	ADV
ajird-1300	96	8	reliably	reliably	ADV
ajird-1300	96	9	observed	observe	VERB
ajird-1300	96	10	in	in	ADP
ajird-1300	96	11	patients	patient	NOUN
ajird-1300	96	12	of	of	ADP
ajird-1300	96	13	the	the	DET
ajird-1300	96	14	2nd	2nd	ADJ
ajird-1300	96	15	group	group	NOUN
ajird-1300	96	16	.	.	PUNCT
ajird-1300	97	1	next	next	ADV
ajird-1300	97	2	,	,	PUNCT
ajird-1300	97	3	we	we	PRON
ajird-1300	97	4	analyzed	analyze	VERB
ajird-1300	97	5	the	the	DET
ajird-1300	97	6	correlation	correlation	NOUN
ajird-1300	97	7	between	between	ADP
ajird-1300	97	8	the	the	DET
ajird-1300	97	9	ghd	ghd	NOUN
ajird-1300	97	10	and	and	CCONJ
ajird-1300	97	11	the	the	DET
ajird-1300	97	12	ghd	ghd	NOUN
ajird-1300	97	13	questionnaire	questionnaire	NOUN
ajird-1300	97	14	data	datum	NOUN
ajird-1300	97	15	in	in	ADP
ajird-1300	97	16	order	order	NOUN
ajird-1300	97	17	to	to	PART
ajird-1300	97	18	study	study	VERB
ajird-1300	97	19	the	the	DET
ajird-1300	97	20	effectiveness	effectiveness	NOUN
ajird-1300	97	21	of	of	ADP
ajird-1300	97	22	its	its	PRON
ajird-1300	97	23	use	use	NOUN
ajird-1300	97	24	.	.	PUNCT
ajird-1300	98	1	these	these	DET
ajird-1300	98	2	data	datum	NOUN
ajird-1300	98	3	are	be	AUX
ajird-1300	98	4	presented	present	VERB
ajird-1300	98	5	in	in	ADP
ajird-1300	98	6	table	table	NOUN
ajird-1300	98	7	7	7	NUM
ajird-1300	98	8	.	.	PUNCT
ajird-1300	98	9	table	table	NOUN
ajird-1300	98	10	7	7	NUM
ajird-1300	98	11	.	.	PUNCT
ajird-1300	98	12	correlation	correlation	NOUN
ajird-1300	98	13	between	between	ADP
ajird-1300	98	14	gh	gh	PROPN
ajird-1300	98	15	deficiency	deficiency	NOUN
ajird-1300	98	16	,	,	PUNCT
ajird-1300	98	17	igf-1	igf-1	NOUN
ajird-1300	98	18	and	and	CCONJ
ajird-1300	98	19	questionnaire	questionnaire	NOUN
ajird-1300	98	20	data	datum	NOUN
ajird-1300	98	21	.	.	PUNCT
ajird-1300	99	1	hormones	hormone	NOUN
ajird-1300	99	2	control	control	PROPN
ajird-1300	99	3	group	group	PROPN
ajird-1300	99	4	i	i	PROPN
ajird-1300	99	5	n=4	n=4	PROPN
ajird-1300	99	6	r	r	PROPN
ajird-1300	99	7	ii	ii	PROPN
ajird-1300	99	8	group	group	NOUN
ajird-1300	99	9	n=17	n=17	NOUN
ajird-1300	99	10	r	r	NOUN
ajird-1300	99	11	grng	grng	NOUN
ajird-1300	99	12	/	/	SYM
ajird-1300	99	13	ml	ml	PROPN
ajird-1300	99	14	3.5	3.5	NUM
ajird-1300	99	15	±	±	NUM
ajird-1300	99	16	0.3	0.3	NUM
ajird-1300	99	17	1,1±	1,1±	NUM
ajird-1300	99	18	0.2	0.2	NUM
ajird-1300	99	19	<	<	NOUN
ajird-1300	99	20	0.05	0.05	NUM
ajird-1300	99	21	0.2±	0.2±	NUM
ajird-1300	99	22	0.01	0.01	NUM
ajird-1300	99	23	<	<	X
ajird-1300	99	24	0.05	0.05	NUM
ajird-1300	99	25	igf-1,ng	igf-1,ng	PROPN
ajird-1300	99	26	/	/	SYM
ajird-1300	99	27	ml	ml	PROPN
ajird-1300	99	28	485	485	NUM
ajird-1300	99	29	±	±	NUM
ajird-1300	99	30	9.8	9.8	NUM
ajird-1300	99	31	156.3±	156.3±	NUM
ajird-1300	99	32	3.3	3.3	NUM
ajird-1300	99	33	>	>	SYM
ajird-1300	99	34	0.5	0.5	NUM
ajird-1300	99	35	129.7±7.5	129.7±7.5	NUM
ajird-1300	99	36	<	<	X
ajird-1300	99	37	0.05	0.05	NUM
ajird-1300	99	38	questionnaire	questionnaire	NOUN
ajird-1300	99	39	data	datum	NOUN
ajird-1300	99	40	7.3±	7.3±	NUM
ajird-1300	99	41	0.4	0.4	NUM
ajird-1300	99	42	9.75±	9.75±	NUM
ajird-1300	99	43	0.4	0.4	NUM
ajird-1300	99	44	>	>	SYM
ajird-1300	99	45	0.5	0.5	NUM
ajird-1300	99	46	17.3±0.3	17.3±0.3	NUM
ajird-1300	99	47	<	<	X
ajird-1300	99	48	0.05	0.05	NUM
ajird-1300	99	49	number	number	NOUN
ajird-1300	99	50	of	of	ADP
ajird-1300	99	51	cases	case	NOUN
ajird-1300	99	52	with	with	ADP
ajird-1300	99	53	significant	significant	ADJ
ajird-1300	99	54	correlation	correlation	NOUN
ajird-1300	99	55	between	between	ADP
ajird-1300	99	56	gh	gh	PROPN
ajird-1300	99	57	deficiency	deficiency	NOUN
ajird-1300	99	58	,	,	PUNCT
ajird-1300	99	59	igf-1	igf-1	NOUN
ajird-1300	99	60	and	and	CCONJ
ajird-1300	99	61	questionnaire	questionnaire	NOUN
ajird-1300	100	1	1	1	NUM
ajird-1300	100	2	<	<	NOUN
ajird-1300	100	3	0.05	0.05	NUM
ajird-1300	100	4	7	7	NUM
ajird-1300	100	5	<	<	X
ajird-1300	100	6	0.05	0.05	NUM
ajird-1300	100	7	american	american	ADJ
ajird-1300	100	8	journal	journal	PROPN
ajird-1300	100	9	of	of	ADP
ajird-1300	100	10	interdisciplinary	interdisciplinary	ADJ
ajird-1300	100	11	research	research	NOUN
ajird-1300	100	12	and	and	CCONJ
ajird-1300	100	13	development	development	NOUN
ajird-1300	100	14	issn	issn	PROPN
ajird-1300	100	15	online	online	NOUN
ajird-1300	100	16	:	:	PUNCT
ajird-1300	100	17	2771	2771	NUM
ajird-1300	100	18	-	-	SYM
ajird-1300	100	19	8948	8948	NUM
ajird-1300	100	20	website	website	NOUN
ajird-1300	100	21	:	:	PUNCT
ajird-1300	100	22	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-1300	100	23	volume	volume	NOUN
ajird-1300	100	24	33	33	NUM
ajird-1300	100	25	,	,	PUNCT
ajird-1300	100	26	october	october	PROPN
ajird-1300	100	27	2024	2024	NUM
ajird-1300	100	28	12	12	NUM
ajird-1300	100	29	|	|	ADV
ajird-1300	100	30	p	p	NOUN
ajird-1300	100	31	a	a	DET
ajird-1300	100	32	g	g	NOUN
ajird-1300	100	33	e	e	X
ajird-1300	100	34	p	p	NOUN
ajird-1300	100	35	–	–	PUNCT
ajird-1300	100	36	reliability	reliability	NOUN
ajird-1300	100	37	of	of	ADP
ajird-1300	100	38	differences	difference	NOUN
ajird-1300	100	39	compared	compare	VERB
ajird-1300	100	40	to	to	ADP
ajird-1300	100	41	the	the	DET
ajird-1300	100	42	norm	norm	NOUN
ajird-1300	100	43	the	the	DET
ajird-1300	100	44	analysis	analysis	NOUN
ajird-1300	100	45	of	of	ADP
ajird-1300	100	46	the	the	DET
ajird-1300	100	47	obtained	obtain	VERB
ajird-1300	100	48	results	result	NOUN
ajird-1300	100	49	showed	show	VERB
ajird-1300	100	50	that	that	SCONJ
ajird-1300	100	51	a	a	DET
ajird-1300	100	52	reliable	reliable	ADJ
ajird-1300	100	53	correlation	correlation	NOUN
ajird-1300	100	54	between	between	ADP
ajird-1300	100	55	significantly	significantly	ADV
ajird-1300	100	56	reduced	reduce	VERB
ajird-1300	100	57	levels	level	NOUN
ajird-1300	100	58	of	of	ADP
ajird-1300	100	59	gh	gh	PROPN
ajird-1300	100	60	,	,	PUNCT
ajird-1300	100	61	igf-1	igf-1	NOUN
ajird-1300	100	62	in	in	ADP
ajird-1300	100	63	blood	blood	NOUN
ajird-1300	100	64	plasma	plasma	NOUN
ajird-1300	100	65	and	and	CCONJ
ajird-1300	100	66	a	a	DET
ajird-1300	100	67	low	low	ADJ
ajird-1300	100	68	score	score	NOUN
ajird-1300	100	69	on	on	ADP
ajird-1300	100	70	the	the	DET
ajird-1300	100	71	ghd	ghd	NOUN
ajird-1300	100	72	in	in	ADP
ajird-1300	100	73	adults	adult	NOUN
ajird-1300	100	74	questionnaire	questionnaire	NOUN
ajird-1300	100	75	was	be	AUX
ajird-1300	100	76	found	find	VERB
ajird-1300	100	77	in	in	ADP
ajird-1300	100	78	8	8	NUM
ajird-1300	100	79	patients	patient	NOUN
ajird-1300	100	80	of	of	ADP
ajird-1300	100	81	both	both	DET
ajird-1300	100	82	groups	group	NOUN
ajird-1300	100	83	,	,	PUNCT
ajird-1300	100	84	which	which	PRON
ajird-1300	100	85	is	be	AUX
ajird-1300	100	86	38.0	38.0	NUM
ajird-1300	100	87	%	%	NOUN
ajird-1300	100	88	of	of	ADP
ajird-1300	100	89	the	the	DET
ajird-1300	100	90	total	total	ADJ
ajird-1300	100	91	number	number	NOUN
ajird-1300	100	92	of	of	ADP
ajird-1300	100	93	patients	patient	NOUN
ajird-1300	100	94	,	,	PUNCT
ajird-1300	100	95	including	include	VERB
ajird-1300	100	96	1	1	NUM
ajird-1300	100	97	(	(	PUNCT
ajird-1300	100	98	25	25	NUM
ajird-1300	100	99	%	%	NOUN
ajird-1300	100	100	)	)	PUNCT
ajird-1300	100	101	patient	patient	NOUN
ajird-1300	100	102	from	from	ADP
ajird-1300	100	103	group	group	NOUN
ajird-1300	100	104	1	1	NUM
ajird-1300	100	105	and	and	CCONJ
ajird-1300	100	106	7	7	NUM
ajird-1300	100	107	(	(	PUNCT
ajird-1300	100	108	41.2	41.2	NUM
ajird-1300	100	109	%	%	NOUN
ajird-1300	100	110	)	)	PUNCT
ajird-1300	100	111	patients	patient	NOUN
ajird-1300	100	112	from	from	ADP
ajird-1300	100	113	group	group	NOUN
ajird-1300	100	114	2	2	NUM
ajird-1300	100	115	.	.	PUNCT
ajird-1300	101	1	it	it	PRON
ajird-1300	101	2	should	should	AUX
ajird-1300	101	3	be	be	AUX
ajird-1300	101	4	noted	note	VERB
ajird-1300	101	5	that	that	SCONJ
ajird-1300	101	6	out	out	ADP
ajird-1300	101	7	of	of	ADP
ajird-1300	101	8	15	15	NUM
ajird-1300	101	9	patients	patient	NOUN
ajird-1300	101	10	with	with	ADP
ajird-1300	101	11	laboratory	laboratory	NOUN
ajird-1300	101	12	-	-	PUNCT
ajird-1300	101	13	confirmed	confirm	VERB
ajird-1300	101	14	ghd	ghd	NOUN
ajird-1300	101	15	in	in	ADP
ajird-1300	101	16	adults	adult	NOUN
ajird-1300	101	17	,	,	PUNCT
ajird-1300	101	18	this	this	DET
ajird-1300	101	19	correlation	correlation	NOUN
ajird-1300	101	20	was	be	AUX
ajird-1300	101	21	found	find	VERB
ajird-1300	101	22	in	in	ADP
ajird-1300	101	23	53.3	53.3	NUM
ajird-1300	101	24	%	%	NOUN
ajird-1300	101	25	.	.	PUNCT
ajird-1300	102	1	thus	thus	ADV
ajird-1300	102	2	,	,	PUNCT
ajird-1300	102	3	the	the	DET
ajird-1300	102	4	effectiveness	effectiveness	NOUN
ajird-1300	102	5	of	of	ADP
ajird-1300	102	6	the	the	DET
ajird-1300	102	7	questionnaire	questionnaire	NOUN
ajird-1300	102	8	in	in	ADP
ajird-1300	102	9	identifying	identify	VERB
ajird-1300	102	10	ghd	ghd	NOUN
ajird-1300	102	11	in	in	ADP
ajird-1300	102	12	adults	adult	NOUN
ajird-1300	102	13	was	be	AUX
ajird-1300	102	14	useful	useful	ADJ
ajird-1300	102	15	in	in	ADP
ajird-1300	102	16	more	more	ADJ
ajird-1300	102	17	than	than	ADP
ajird-1300	102	18	half	half	NOUN
ajird-1300	102	19	of	of	ADP
ajird-1300	102	20	the	the	DET
ajird-1300	102	21	patients	patient	NOUN
ajird-1300	102	22	with	with	ADP
ajird-1300	102	23	ghd	ghd	NOUN
ajird-1300	102	24	in	in	ADP
ajird-1300	102	25	adults	adult	NOUN
ajird-1300	102	26	,	,	PUNCT
ajird-1300	102	27	which	which	PRON
ajird-1300	102	28	confirms	confirm	VERB
ajird-1300	102	29	the	the	DET
ajird-1300	102	30	literature	literature	NOUN
ajird-1300	102	31	data	datum	NOUN
ajird-1300	102	32	on	on	ADP
ajird-1300	102	33	the	the	DET
ajird-1300	102	34	need	need	NOUN
ajird-1300	102	35	to	to	PART
ajird-1300	102	36	use	use	VERB
ajird-1300	102	37	it	it	PRON
ajird-1300	102	38	in	in	ADP
ajird-1300	102	39	the	the	DET
ajird-1300	102	40	dynamics	dynamic	NOUN
ajird-1300	102	41	of	of	ADP
ajird-1300	102	42	monitoring	monitor	VERB
ajird-1300	102	43	patients	patient	NOUN
ajird-1300	102	44	in	in	ADP
ajird-1300	102	45	order	order	NOUN
ajird-1300	102	46	to	to	PART
ajird-1300	102	47	track	track	VERB
ajird-1300	102	48	and	and	CCONJ
ajird-1300	102	49	assess	assess	VERB
ajird-1300	102	50	their	their	PRON
ajird-1300	102	51	quality	quality	NOUN
ajird-1300	102	52	of	of	ADP
ajird-1300	102	53	life	life	NOUN
ajird-1300	102	54	in	in	ADP
ajird-1300	102	55	outpatient	outpatient	NOUN
ajird-1300	102	56	settings	setting	NOUN
ajird-1300	102	57	.	.	PUNCT
ajird-1300	103	1	conclusions	conclusion	NOUN
ajird-1300	103	2	1	1	X
ajird-1300	103	3	)	)	PUNCT
ajird-1300	103	4	it	it	PRON
ajird-1300	103	5	was	be	AUX
ajird-1300	103	6	found	find	VERB
ajird-1300	103	7	that	that	SCONJ
ajird-1300	103	8	the	the	DET
ajird-1300	103	9	frequency	frequency	NOUN
ajird-1300	103	10	of	of	ADP
ajird-1300	103	11	ghd	ghd	NOUN
ajird-1300	103	12	in	in	ADP
ajird-1300	103	13	adults	adult	NOUN
ajird-1300	103	14	in	in	ADP
ajird-1300	103	15	the	the	DET
ajird-1300	103	16	examined	examine	VERB
ajird-1300	103	17	patients	patient	NOUN
ajird-1300	103	18	with	with	ADP
ajird-1300	103	19	coronary	coronary	ADJ
ajird-1300	103	20	heart	heart	NOUN
ajird-1300	103	21	disease	disease	NOUN
ajird-1300	103	22	of	of	ADP
ajird-1300	103	23	both	both	DET
ajird-1300	103	24	groups	group	NOUN
ajird-1300	103	25	was	be	AUX
ajird-1300	103	26	15	15	NUM
ajird-1300	103	27	cases	case	NOUN
ajird-1300	103	28	out	out	ADP
ajird-1300	103	29	of	of	ADP
ajird-1300	103	30	21	21	NUM
ajird-1300	103	31	(	(	PUNCT
ajird-1300	103	32	71.4	71.4	NUM
ajird-1300	103	33	%	%	NOUN
ajird-1300	103	34	)	)	PUNCT
ajird-1300	103	35	.	.	PUNCT
ajird-1300	104	1	at	at	ADP
ajird-1300	104	2	the	the	DET
ajird-1300	104	3	same	same	ADJ
ajird-1300	104	4	time	time	NOUN
ajird-1300	104	5	,	,	PUNCT
ajird-1300	104	6	in	in	ADP
ajird-1300	104	7	8	8	NUM
ajird-1300	104	8	(	(	PUNCT
ajird-1300	104	9	53.3	53.3	NUM
ajird-1300	104	10	%	%	NOUN
ajird-1300	104	11	)	)	PUNCT
ajird-1300	104	12	patients	patient	NOUN
ajird-1300	104	13	with	with	ADP
ajird-1300	104	14	laboratory	laboratory	NOUN
ajird-1300	104	15	-	-	PUNCT
ajird-1300	104	16	determined	determine	VERB
ajird-1300	104	17	ghd	ghd	NOUN
ajird-1300	104	18	in	in	ADP
ajird-1300	104	19	adults	adult	NOUN
ajird-1300	104	20	,	,	PUNCT
ajird-1300	104	21	a	a	DET
ajird-1300	104	22	reliable	reliable	ADJ
ajird-1300	104	23	decrease	decrease	NOUN
ajird-1300	104	24	in	in	ADP
ajird-1300	104	25	the	the	DET
ajird-1300	104	26	concentration	concentration	NOUN
ajird-1300	104	27	of	of	ADP
ajird-1300	104	28	igf-1	igf-1	NOUN
ajird-1300	104	29	in	in	ADP
ajird-1300	104	30	the	the	DET
ajird-1300	104	31	blood	blood	NOUN
ajird-1300	104	32	plasma	plasma	NOUN
ajird-1300	104	33	was	be	AUX
ajird-1300	104	34	noted	note	VERB
ajird-1300	104	35	.	.	PUNCT
ajird-1300	105	1	2)among	2)among	NUM
ajird-1300	106	1	the	the	DET
ajird-1300	106	2	metabolic	metabolic	NOUN
ajird-1300	106	3	disorders	disorder	NOUN
ajird-1300	106	4	in	in	ADP
ajird-1300	106	5	the	the	DET
ajird-1300	106	6	examined	examine	VERB
ajird-1300	106	7	patients	patient	NOUN
ajird-1300	106	8	,	,	PUNCT
ajird-1300	106	9	the	the	DET
ajird-1300	106	10	following	follow	VERB
ajird-1300	106	11	were	be	AUX
ajird-1300	106	12	encountered	encounter	VERB
ajird-1300	106	13	:	:	PUNCT
ajird-1300	106	14	obesity	obesity	NOUN
ajird-1300	106	15	of	of	ADP
ajird-1300	106	16	1	1	NUM
ajird-1300	106	17	-	-	SYM
ajird-1300	106	18	2	2	NUM
ajird-1300	106	19	degrees	degree	NOUN
ajird-1300	106	20	–	–	PUNCT
ajird-1300	106	21	in	in	ADP
ajird-1300	106	22	20	20	NUM
ajird-1300	106	23	patients	patient	NOUN
ajird-1300	106	24	out	out	ADP
ajird-1300	106	25	of	of	ADP
ajird-1300	106	26	the	the	DET
ajird-1300	106	27	total	total	ADJ
ajird-1300	106	28	number	number	NOUN
ajird-1300	106	29	of	of	ADP
ajird-1300	106	30	patients	patient	NOUN
ajird-1300	106	31	(	(	PUNCT
ajird-1300	106	32	95.2	95.2	NUM
ajird-1300	106	33	%	%	NOUN
ajird-1300	106	34	)	)	PUNCT
ajird-1300	106	35	,	,	PUNCT
ajird-1300	106	36	diabetes	diabetes	NOUN
ajird-1300	106	37	mellitus	mellitus	NOUN
ajird-1300	106	38	type	type	VERB
ajird-1300	106	39	2	2	NUM
ajird-1300	106	40	–	–	PUNCT
ajird-1300	106	41	in	in	ADP
ajird-1300	106	42	7	7	NUM
ajird-1300	106	43	(	(	PUNCT
ajird-1300	106	44	33.3	33.3	NUM
ajird-1300	106	45	%	%	NOUN
ajird-1300	106	46	)	)	PUNCT
ajird-1300	106	47	,	,	PUNCT
ajird-1300	106	48	3	3	X
ajird-1300	106	49	)	)	PUNCT
ajird-1300	106	50	using	use	VERB
ajird-1300	106	51	the	the	DET
ajird-1300	106	52	questionnairefor	questionnairefor	NOUN
ajird-1300	106	53	the	the	DET
ajird-1300	106	54	detection	detection	NOUN
ajird-1300	106	55	of	of	ADP
ajird-1300	106	56	aghd	aghd	NOUN
ajird-1300	106	57	(	(	PUNCT
ajird-1300	106	58	qol	qol	NOUN
ajird-1300	106	59	aghd	aghd	PROPN
ajird-1300	106	60	)	)	PUNCT
ajird-1300	106	61	revealed	reveal	VERB
ajird-1300	106	62	a	a	DET
ajird-1300	106	63	reliable	reliable	ADJ
ajird-1300	106	64	decrease	decrease	NOUN
ajird-1300	106	65	in	in	ADP
ajird-1300	106	66	scores	score	NOUN
ajird-1300	106	67	in	in	ADP
ajird-1300	106	68	15	15	NUM
ajird-1300	106	69	(	(	PUNCT
ajird-1300	106	70	71.4	71.4	NUM
ajird-1300	106	71	%	%	NOUN
ajird-1300	106	72	)	)	PUNCT
ajird-1300	106	73	patients	patient	NOUN
ajird-1300	106	74	during	during	ADP
ajird-1300	106	75	the	the	DET
ajird-1300	106	76	preliminary	preliminary	ADJ
ajird-1300	106	77	survey	survey	NOUN
ajird-1300	106	78	.	.	PUNCT
ajird-1300	107	1	a	a	DET
ajird-1300	107	2	reliable	reliable	ADJ
ajird-1300	107	3	correlation	correlation	NOUN
ajird-1300	107	4	between	between	ADP
ajird-1300	107	5	significantly	significantly	ADV
ajird-1300	107	6	reduced	reduce	VERB
ajird-1300	107	7	levels	level	NOUN
ajird-1300	107	8	of	of	ADP
ajird-1300	107	9	gh	gh	PROPN
ajird-1300	107	10	,	,	PUNCT
ajird-1300	107	11	igf-1	igf-1	NOUN
ajird-1300	107	12	in	in	ADP
ajird-1300	107	13	blood	blood	NOUN
ajird-1300	107	14	plasma	plasma	NOUN
ajird-1300	107	15	and	and	CCONJ
ajird-1300	107	16	a	a	DET
ajird-1300	107	17	low	low	ADJ
ajird-1300	107	18	score	score	NOUN
ajird-1300	107	19	on	on	ADP
ajird-1300	107	20	the	the	DET
ajird-1300	107	21	aghd	aghd	NOUN
ajird-1300	107	22	questionnaire	questionnaire	NOUN
ajird-1300	107	23	was	be	AUX
ajird-1300	107	24	found	find	VERB
ajird-1300	107	25	in	in	ADP
ajird-1300	107	26	8	8	NUM
ajird-1300	107	27	patients	patient	NOUN
ajird-1300	107	28	of	of	ADP
ajird-1300	107	29	both	both	DET
ajird-1300	107	30	groups	group	NOUN
ajird-1300	107	31	this	this	PRON
ajird-1300	107	32	is	be	AUX
ajird-1300	107	33	38.0	38.0	NUM
ajird-1300	107	34	%	%	NOUN
ajird-1300	107	35	of	of	ADP
ajird-1300	107	36	the	the	DET
ajird-1300	107	37	total	total	ADJ
ajird-1300	107	38	number	number	NOUN
ajird-1300	107	39	of	of	ADP
ajird-1300	107	40	patients	patient	NOUN
ajird-1300	107	41	.	.	PUNCT
ajird-1300	108	1	references	reference	NOUN
ajird-1300	108	2	1	1	NUM
ajird-1300	108	3	.	.	PUNCT
ajird-1300	109	1	dedov	dedov	PROPN
ajird-1300	109	2	i.i	i.i	PROPN
ajird-1300	109	3	.	.	PROPN
ajird-1300	109	4	,	,	PUNCT
ajird-1300	109	5	peterkova	peterkova	PROPN
ajird-1300	109	6	v.a	v.a	PROPN
ajird-1300	109	7	.	.	PROPN
ajird-1300	109	8	,	,	PUNCT
ajird-1300	109	9	bezlepkina	bezlepkina	PROPN
ajird-1300	109	10	o.b./	o.b./	PROPN
ajird-1300	109	11	national	national	PROPN
ajird-1300	109	12	consensus	consensus	NOUN
ajird-1300	109	13	"	"	PUNCT
ajird-1300	109	14	use	use	NOUN
ajird-1300	109	15	of	of	ADP
ajird-1300	109	16	growth	growth	NOUN
ajird-1300	109	17	hormone	hormone	NOUN
ajird-1300	109	18	in	in	ADP
ajird-1300	109	19	adults	adult	NOUN
ajird-1300	109	20	and	and	CCONJ
ajird-1300	109	21	children	child	NOUN
ajird-1300	109	22	"	"	PUNCT
ajird-1300	109	23	.	.	PUNCT
ajird-1300	110	1	iii	iii	X
ajird-1300	110	2	all	all	ADV
ajird-1300	110	3	-	-	ADJ
ajird-1300	110	4	russian	russian	ADJ
ajird-1300	110	5	scientific	scientific	ADJ
ajird-1300	110	6	and	and	CCONJ
ajird-1300	110	7	practical	practical	ADJ
ajird-1300	110	8	conference	conference	NOUN
ajird-1300	110	9	//	//	PUNCT
ajird-1300	110	10	"	"	PUNCT
ajird-1300	110	11	actual	actual	ADJ
ajird-1300	110	12	problems	problem	NOUN
ajird-1300	110	13	of	of	ADP
ajird-1300	110	14	neuroendocrinology	neuroendocrinology	NOUN
ajird-1300	110	15	"	"	PUNCT
ajird-1300	110	16	moscow	moscow	PROPN
ajird-1300	110	17	,	,	PUNCT
ajird-1300	110	18	october	october	PROPN
ajird-1300	110	19	6	6	NUM
ajird-1300	110	20	-	-	SYM
ajird-1300	110	21	7	7	NUM
ajird-1300	110	22	,	,	PUNCT
ajird-1300	110	23	2003	2003	NUM
ajird-1300	110	24	2	2	NUM
ajird-1300	110	25	.	.	PUNCT
ajird-1300	110	26	camacho	camacho	PROPN
ajird-1300	110	27	p.	p.	PROPN
ajird-1300	110	28	,	,	PUNCT
ajird-1300	110	29	gariba	gariba	PROPN
ajird-1300	110	30	h.	h.	PROPN
ajird-1300	110	31	,	,	PUNCT
ajird-1300	110	32	sizemora	sizemora	PROPN
ajird-1300	110	33	g.	g.	PROPN
ajird-1300	110	34	/	/	PUNCT
ajird-1300	110	35	"	"	PUNCT
ajird-1300	110	36	evidence	evidence	NOUN
ajird-1300	110	37	-	-	PUNCT
ajird-1300	110	38	based	base	VERB
ajird-1300	110	39	endocrinology	endocrinology	NOUN
ajird-1300	110	40	"	"	PUNCT
ajird-1300	111	1	//	//	X
ajird-1300	111	2	moscow	moscow	PROPN
ajird-1300	111	3	,	,	PUNCT
ajird-1300	111	4	2009	2009	NUM
ajird-1300	111	5	,	,	PUNCT
ajird-1300	111	6	632	632	NUM
ajird-1300	112	1	p.	p.	NOUN
ajird-1300	112	2	3.shchukina	3.shchukina	NUM
ajird-1300	112	3	.	.	PUNCT
ajird-1300	113	1	v.n./"the	v.n./"the	DET
ajird-1300	113	2	role	role	NOUN
ajird-1300	113	3	of	of	ADP
ajird-1300	113	4	somatotropic	somatotropic	ADJ
ajird-1300	113	5	insufficiency	insufficiency	NOUN
ajird-1300	113	6	in	in	ADP
ajird-1300	113	7	the	the	DET
ajird-1300	113	8	genesis	genesis	NOUN
ajird-1300	113	9	of	of	ADP
ajird-1300	113	10	coronary	coronary	ADJ
ajird-1300	113	11	heart	heart	NOUN
ajird-1300	113	12	disease	disease	NOUN
ajird-1300	113	13	in	in	ADP
ajird-1300	113	14	patients	patient	NOUN
ajird-1300	113	15	with	with	ADP
ajird-1300	113	16	type	type	NOUN
ajird-1300	113	17	2	2	NUM
ajird-1300	113	18	diabetes	diabetes	NOUN
ajird-1300	113	19	mellitus	mellitus	NOUN
ajird-1300	113	20	"	"	PUNCT
ajird-1300	113	21	//	//	PROPN
ajird-1300	113	22	author	author	NOUN
ajird-1300	113	23	,	,	PUNCT
ajird-1300	113	24	phd	phd	PROPN
ajird-1300	113	25	.	.	PUNCT
ajird-1300	113	26	moscow	moscow	PROPN
ajird-1300	113	27	,	,	PUNCT
ajird-1300	113	28	2006	2006	NUM
ajird-1300	113	29	,	,	PUNCT
ajird-1300	113	30	28	28	NUM
ajird-1300	113	31	p.	p.	NOUN
ajird-1300	113	32	183	183	NUM
ajird-1300	113	33	)	)	PUNCT
ajird-1300	113	34	4.urmanova	4.urmanova	NUM
ajird-1300	113	35	yu.m	yu.m	NOUN
ajird-1300	113	36	.	.	PROPN
ajird-1300	113	37	,	,	PUNCT
ajird-1300	113	38	shakirova	shakirova	VERB
ajird-1300	114	1	m.yu	m.yu	PROPN
ajird-1300	114	2	.	.	PROPN
ajird-1300	114	3	,	,	PUNCT
ajird-1300	114	4	rikhsieva	rikhsieva	PROPN
ajird-1300	114	5	n.t	n.t	PROPN
ajird-1300	114	6	.	.	PROPN
ajird-1300	114	7	,	,	PUNCT
ajird-1300	114	8	abduvakhabova	abduvakhabova	PROPN
ajird-1300	115	1	m.b	m.b	PROPN
ajird-1300	115	2	.	.	PROPN
ajird-1300	115	3	,	,	PUNCT
ajird-1300	115	4	tursunkulov	tursunkulov	PROPN
ajird-1300	115	5	o.a	o.a	PROPN
ajird-1300	115	6	.	.	PROPN
ajird-1300	116	1	"complications	"complication	NOUN
ajird-1300	116	2	of	of	ADP
ajird-1300	116	3	growth	growth	NOUN
ajird-1300	116	4	hormone	hormone	NOUN
ajird-1300	116	5	deficiency	deficiency	NOUN
ajird-1300	116	6	in	in	ADP
ajird-1300	116	7	adults"//journal	adults"//journal	PROPN
ajird-1300	116	8	of	of	ADP
ajird-1300	116	9	theoretical	theoretical	ADJ
ajird-1300	116	10	and	and	CCONJ
ajird-1300	116	11	clinical	clinical	ADJ
ajird-1300	116	12	medicine	medicine	NOUN
ajird-1300	116	13	,	,	PUNCT
ajird-1300	116	14	2018	2018	NUM
ajird-1300	116	15	,	,	PUNCT
ajird-1300	116	16	no	no	INTJ
ajird-1300	116	17	.	.	NOUN
ajird-1300	116	18	5	5	NUM
ajird-1300	116	19	,	,	PUNCT
ajird-1300	116	20	pp	pp	ADJ
ajird-1300	116	21	.	.	PUNCT
ajird-1300	117	1	100	100	NUM
ajird-1300	117	2	-	-	SYM
ajird-1300	117	3	104	104	NUM
ajird-1300	117	4	5.urmanova	5.urmanova	NUM
ajird-1300	117	5	yu.m	yu.m	NOUN
ajird-1300	117	6	.	.	PROPN
ajird-1300	117	7	,	,	PUNCT
ajird-1300	117	8	shakirova	shakirova	VERB
ajird-1300	118	1	m.yu	m.yu	PROPN
ajird-1300	118	2	.	.	PROPN
ajird-1300	118	3	,	,	PUNCT
ajird-1300	118	4	rikhsieva	rikhsieva	PROPN
ajird-1300	118	5	n.t	n.t	PROPN
ajird-1300	118	6	.	.	PROPN
ajird-1300	118	7	,	,	PUNCT
ajird-1300	118	8	khodzhaeva	khodzhaeva	PROPN
ajird-1300	118	9	f.s	f.s	PROPN
ajird-1300	118	10	.	.	PROPN
ajird-1300	118	11	"some	"some	ADJ
ajird-1300	118	12	risk	risk	NOUN
ajird-1300	118	13	factors	factor	NOUN
ajird-1300	118	14	for	for	ADP
ajird-1300	118	15	recurrence	recurrence	NOUN
ajird-1300	118	16	of	of	ADP
ajird-1300	118	17	inactive	inactive	ADJ
ajird-1300	118	18	pituitary	pituitary	ADJ
ajird-1300	118	19	adenomas	adenoma	NOUN
ajird-1300	118	20	in	in	ADP
ajird-1300	118	21	patients	patient	NOUN
ajird-1300	118	22	with	with	ADP
ajird-1300	118	23	growth	growth	NOUN
ajird-1300	118	24	hormone	hormone	NOUN
ajird-1300	118	25	american	american	PROPN
ajird-1300	118	26	journal	journal	PROPN
ajird-1300	118	27	of	of	ADP
ajird-1300	118	28	interdisciplinary	interdisciplinary	ADJ
ajird-1300	118	29	research	research	NOUN
ajird-1300	118	30	and	and	CCONJ
ajird-1300	118	31	development	development	NOUN
ajird-1300	118	32	issn	issn	PROPN
ajird-1300	118	33	online	online	NOUN
ajird-1300	118	34	:	:	PUNCT
ajird-1300	118	35	2771	2771	NUM
ajird-1300	118	36	-	-	SYM
ajird-1300	118	37	8948	8948	NUM
ajird-1300	118	38	website	website	NOUN
ajird-1300	118	39	:	:	PUNCT
ajird-1300	118	40	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-1300	118	41	volume	volume	NOUN
ajird-1300	118	42	33	33	NUM
ajird-1300	118	43	,	,	PUNCT
ajird-1300	118	44	october	october	PROPN
ajird-1300	118	45	2024	2024	NUM
ajird-1300	118	46	13	13	NUM
ajird-1300	119	1	|	|	ADV
ajird-1300	119	2	p	p	NOUN
ajird-1300	119	3	a	a	DET
ajird-1300	119	4	g	g	NOUN
ajird-1300	119	5	e	e	NOUN
ajird-1300	119	6	deficiency	deficiency	NOUN
ajird-1300	119	7	.	.	PUNCT
ajird-1300	120	1	"//	"//	PROPN
ajird-1300	120	2	international	international	ADJ
ajird-1300	120	3	endocrinology	endocrinology	NOUN
ajird-1300	120	4	journal	journal	NOUN
ajird-1300	120	5	,	,	PUNCT
ajird-1300	120	6	ukraine	ukraine	NOUN
ajird-1300	120	7	,	,	PUNCT
ajird-1300	120	8	kyiv	kyiv	ADJ
ajird-1300	120	9	shakhri	shakhri	NOUN
ajird-1300	120	10	,	,	PUNCT
ajird-1300	120	11	no	no	INTJ
ajird-1300	120	12	.	.	NOUN
ajird-1300	120	13	2	2	NUM
ajird-1300	120	14	,	,	PUNCT
ajird-1300	120	15	vol	vol	NOUN
ajird-1300	120	16	.	.	PROPN
ajird-1300	120	17	5	5	NUM
ajird-1300	120	18	,	,	PUNCT
ajird-1300	120	19	2019	2019	NUM
ajird-1300	120	20	,	,	PUNCT
ajird-1300	120	21	pp	pp	ADJ
ajird-1300	120	22	.	.	PUNCT
ajird-1300	121	1	46	46	NUM
ajird-1300	121	2	-	-	SYM
ajird-1300	121	3	50	50	NUM
ajird-1300	121	4	6.attanavio	6.attanavio	NUM
ajird-1300	121	5	a.f	a.f	PROPN
ajird-1300	121	6	.	.	PROPN
ajird-1300	121	7	,	,	PUNCT
ajird-1300	121	8	d.	d.	PROPN
ajird-1300	121	9	mo	mo	PROPN
ajird-1300	121	10	.	.	PROPN
ajird-1300	121	11	,	,	PUNCT
ajird-1300	121	12	e.m	e.m	PROPN
ajird-1300	121	13	.	.	PUNCT
ajird-1300	122	1	erfug.the	erfug.the	DET
ajird-1300	122	2	frequency	frequency	NOUN
ajird-1300	122	3	of	of	ADP
ajird-1300	122	4	metabolic	metabolic	NOUN
ajird-1300	122	5	syndrome	syndrome	NOUN
ajird-1300	122	6	in	in	ADP
ajird-1300	122	7	patients	patient	NOUN
ajird-1300	122	8	with	with	ADP
ajird-1300	122	9	hypopituitarism	hypopituitarism	NOUN
ajird-1300	122	10	and	and	CCONJ
ajird-1300	122	11	ghd	ghd	NOUN
ajird-1300	122	12	before	before	ADP
ajird-1300	122	13	and	and	CCONJ
ajird-1300	122	14	after	after	ADP
ajird-1300	122	15	replacement	replacement	NOUN
ajird-1300	122	16	therapy//j	therapy//j	NOUN
ajird-1300	122	17	clin	clin	PROPN
ajird-1300	122	18	endoc	endoc	ADV
ajird-1300	122	19	and	and	CCONJ
ajird-1300	122	20	met.n1	met.n1	NOUN
ajird-1300	122	21	95	95	NUM
ajird-1300	122	22	:	:	PUNCT
ajird-1300	122	23	74	74	NUM
ajird-1300	122	24	-	-	SYM
ajird-1300	122	25	81	81	NUM
ajird-1300	122	26	,	,	PUNCT
ajird-1300	122	27	2010	2010	NUM
ajird-1300	122	28	7.grossman	7.grossman	NUM
ajird-1300	122	29	ab.growth	ab.growth	NOUN
ajird-1300	122	30	hormone	hormone	NOUN
ajird-1300	122	31	deficiency	deficiency	NOUN
ajird-1300	122	32	in	in	ADP
ajird-1300	122	33	adults//london	adults//london	PROPN
ajird-1300	122	34	,	,	PUNCT
ajird-1300	122	35	copyright	copyright	NOUN
ajird-1300	122	36	2005	2005	NUM
ajird-1300	122	37	by	by	ADP
ajird-1300	122	38	s.	s.	PROPN
ajird-1300	122	39	karger	karger	PROPN
ajird-1300	122	40	ag	ag	PROPN
ajird-1300	122	41	,	,	PUNCT
ajird-1300	122	42	po	po	PROPN
ajird-1300	122	43	box	box	PROPN
ajird-1300	122	44	,	,	PUNCT
ajird-1300	122	45	ch-4009	ch-4009	PROPN
ajird-1300	122	46	basel	basel	PROPN
ajird-1300	122	47	(	(	PUNCT
ajird-1300	122	48	switzerland	switzerland	PROPN
ajird-1300	122	49	)	)	PUNCT
ajird-1300	122	50	,	,	PUNCT
ajird-1300	122	51	tom	tom	PROPN
ajird-1300	122	52	33	33	NUM
ajird-1300	122	53	,	,	PUNCT
ajird-1300	122	54	315	315	NUM
ajird-1300	122	55	pages	page	NOUN
ajird-1300	122	56	8	8	NUM
ajird-1300	122	57	.	.	PUNCT
ajird-1300	123	1	jol	jol	PROPN
ajird-1300	123	2	jorgensen	jorgensen	PROPN
ajird-1300	123	3	,	,	PUNCT
ajird-1300	123	4	js	js	PROPN
ajird-1300	123	5	christiansen	christiansen	PROPN
ajird-1300	123	6	/	/	SYM
ajird-1300	123	7	ghd	ghd	PROPN
ajird-1300	123	8	in	in	ADP
ajird-1300	123	9	adults//denmark	adults//denmark	PROPN
ajird-1300	123	10	,	,	PUNCT
ajird-1300	123	11	frontiers	frontier	NOUN
ajird-1300	123	12	of	of	ADP
ajird-1300	123	13	hormone	hormone	NOUN
ajird-1300	123	14	research	research	NOUN
ajird-1300	123	15	,	,	PUNCT
ajird-1300	123	16	editor	editor	NOUN
ajird-1300	123	17	ab	ab	PROPN
ajird-1300	123	18	grossman	grossman	PROPN
ajird-1300	123	19	,	,	PUNCT
ajird-1300	123	20	vol.33	vol.33	PROPN
ajird-1300	123	21	,	,	PUNCT
ajird-1300	123	22	2005	2005	NUM
ajird-1300	123	23	,	,	PUNCT
ajird-1300	123	24	pg	pg	INTJ
ajird-1300	123	25	.	.	PROPN
ajird-1300	123	26	260	260	NUM
ajird-1300	123	27	9.johannson	9.johannson	NUM
ajird-1300	123	28	g	g	NOUN
ajird-1300	123	29	,	,	PUNCT
ajird-1300	123	30	bengtsson	bengtsson	PROPN
ajird-1300	123	31	ba	ba	PROPN
ajird-1300	123	32	,	,	PUNCT
ajird-1300	123	33	andersson	andersson	PROPN
ajird-1300	123	34	b.long	b.long	ADJ
ajird-1300	123	35	term	term	NOUN
ajird-1300	123	36	cardiovascular	cardiovascular	ADJ
ajird-1300	123	37	effects	effect	NOUN
ajird-1300	123	38	of	of	ADP
ajird-1300	123	39	gh	gh	PROPN
ajird-1300	123	40	treatment	treatment	NOUN
ajird-1300	123	41	on	on	ADP
ajird-1300	123	42	cardiac	cardiac	ADJ
ajird-1300	123	43	structure	structure	NOUN
ajird-1300	123	44	.	.	PUNCT
ajird-1300	124	1	//clin	//clin	PROPN
ajird-1300	124	2	endocrinol	endocrinol	NOUN
ajird-1300	124	3	(	(	PUNCT
ajird-1300	124	4	oxf	oxf	PROPN
ajird-1300	124	5	)	)	PUNCT
ajird-1300	124	6	1996;45:305	1996;45:305	PROPN
ajird-1300	124	7	-	-	SYM
ajird-1300	124	8	314	314	NUM
ajird-1300	124	9	.	.	PUNCT
ajird-1300	125	1	10.ken	10.ken	PROPN
ajird-1300	125	2	ky	ky	NOUN
ajird-1300	125	3	ho	ho	PROPN
ajird-1300	125	4	/consensus	/consensus	PROPN
ajird-1300	125	5	quidelines	quidelines	PROPN
ajird-1300	125	6	for	for	ADP
ajird-1300	125	7	the	the	DET
ajird-1300	125	8	diagnosis	diagnosis	NOUN
ajird-1300	125	9	and	and	CCONJ
ajird-1300	125	10	treatment	treatment	NOUN
ajird-1300	125	11	of	of	ADP
ajird-1300	125	12	adults	adult	NOUN
ajird-1300	125	13	with	with	ADP
ajird-1300	125	14	ghdeficiency	ghdeficiency	NOUN
ajird-1300	125	15	11	11	NUM
ajird-1300	125	16	:	:	PUNCT
ajird-1300	125	17	a	a	DET
ajird-1300	125	18	statement	statement	NOUN
ajird-1300	125	19	of	of	ADP
ajird-1300	125	20	the	the	DET
ajird-1300	125	21	gh	gh	PROPN
ajird-1300	125	22	research	research	PROPN
ajird-1300	125	23	society	society	NOUN
ajird-1300	125	24	in	in	ADP
ajird-1300	125	25	association	association	NOUN
ajird-1300	125	26	with	with	ADP
ajird-1300	125	27	the	the	DET
ajird-1300	125	28	european	european	PROPN
ajird-1300	125	29	society	society	PROPN
ajird-1300	125	30	for	for	ADP
ajird-1300	125	31	pediatric	pediatric	ADJ
ajird-1300	125	32	endocrinology	endocrinology	NOUN
ajird-1300	125	33	,	,	PUNCT
ajird-1300	125	34	lawson	lawson	PROPN
ajird-1300	125	35	wilkins	wilkins	PROPN
ajird-1300	125	36	society	society	PROPN
ajird-1300	125	37	,	,	PUNCT
ajird-1300	125	38	european	european	ADJ
ajird-1300	125	39	society	society	NOUN
ajird-1300	125	40	of	of	ADP
ajird-1300	125	41	endocrinology	endocrinology	NOUN
ajird-1300	125	42	,	,	PUNCT
ajird-1300	125	43	japan	japan	PROPN
ajird-1300	125	44	endocrine	endocrine	PROPN
ajird-1300	125	45	society	society	NOUN
ajird-1300	125	46	,	,	PUNCT
ajird-1300	125	47	and	and	CCONJ
ajird-1300	125	48	endocrine	endocrine	ADJ
ajird-1300	125	49	society	society	NOUN
ajird-1300	125	50	of	of	ADP
ajird-1300	125	51	australia	australia	PROPN
ajird-1300	125	52	//	//	PROPN
ajird-1300	125	53	european	european	PROPN
ajird-1300	125	54	journal	journal	PROPN
ajird-1300	125	55	of	of	ADP
ajird-1300	125	56	endocrinology	endocrinology	NOUN
ajird-1300	125	57	(	(	PUNCT
ajird-1300	125	58	2007	2007	NUM
ajird-1300	125	59	)	)	PUNCT
ajird-1300	125	60	157	157	NUM
ajird-1300	125	61	–	–	PUNCT
ajird-1300	125	62	695	695	NUM
ajird-1300	125	63	-	-	SYM
ajird-1300	125	64	700	700	NUM
ajird-1300	125	65	)	)	PUNCT
ajird-1300	125	66	11	11	NUM
ajird-1300	125	67	.	.	PUNCT
ajird-1300	126	1	syuzen	syuzen	ADJ
ajird-1300	126	2	m.	m.	NOUN
ajird-1300	126	3	veb	veb	PROPN
ajird-1300	126	4	,	,	PUNCT
ajird-1300	126	5	daogun	daogun	PROPN
ajird-1300	126	6	mo	mo	PROPN
ajird-1300	126	7	,	,	PUNCT
ajird-1300	126	8	stiven	stiven	ADV
ajird-1300	126	9	b.dg/metabolic	b.dg/metabolic	ADJ
ajird-1300	126	10	,	,	PUNCT
ajird-1300	126	11	cardio	cardio	NOUN
ajird-1300	126	12	-	-	PUNCT
ajird-1300	126	13	vascular	vascular	NOUN
ajird-1300	126	14	,	,	PUNCT
ajird-1300	126	15	and	and	CCONJ
ajird-1300	126	16	cerebrovascular	cerebrovascular	ADJ
ajird-1300	126	17	complications	complication	NOUN
ajird-1300	126	18	in	in	ADP
ajird-1300	126	19	patients	patient	NOUN
ajird-1300	126	20	with	with	ADP
ajird-1300	126	21	growth	growth	NOUN
ajird-1300	126	22	hormone	hormone	NOUN
ajird-1300	126	23	deficiency	deficiency	NOUN
ajird-1300	126	24	and	and	CCONJ
ajird-1300	126	25	with	with	ADP
ajird-1300	126	26	cushing	cushing	NOUN
ajird-1300	126	27	disease	disease	NOUN
ajird-1300	126	28	or	or	CCONJ
ajird-1300	126	29	nfpa//journ	nfpa//journ	VERB
ajird-1300	126	30	clin	clin	PROPN
ajird-1300	126	31	end	end	NOUN
ajird-1300	126	32	and	and	CCONJ
ajird-1300	126	33	met	meet	VERB
ajird-1300	126	34	.	.	PUNCT
ajird-1300	126	35	,	,	PUNCT
ajird-1300	126	36	2007	2007	NUM
ajird-1300	126	37	,	,	PUNCT
ajird-1300	126	38	vol	vol	NOUN
ajird-1300	126	39	95	95	NUM
ajird-1300	126	40	,	,	PUNCT
ajird-1300	126	41	n2	n2	ADJ
ajird-1300	126	42	,	,	PUNCT
ajird-1300	126	43	pg	pg	NOUN
ajird-1300	126	44	201	201	NUM
ajird-1300	126	45	-	-	SYM
ajird-1300	126	46	210	210	NUM
ajird-1300	126	47	12.tomlinson	12.tomlinson	NUM
ajird-1300	126	48	j.kassociation	j.kassociation	NOUN
ajird-1300	126	49	between	between	ADP
ajird-1300	126	50	premature	premature	ADJ
ajird-1300	126	51	mortality	mortality	NOUN
ajird-1300	126	52	and	and	CCONJ
ajird-1300	126	53	hypopituitarism	hypopituitarism	PROPN
ajird-1300	126	54	/	/	SYM
ajird-1300	126	55	et	et	PROPN
ajird-1300	126	56	all//lancet	all//lancet	PROPN
ajird-1300	126	57	,	,	PUNCT
ajird-1300	126	58	.2001;357:425	.2001;357:425	PROPN
ajird-1300	126	59	-	-	PUNCT
ajird-1300	126	60	431	431	NUM
ajird-1300	126	61	)	)	PUNCT
ajird-1300	126	62	13.ur	13.ur	NUM
ajird-1300	126	63	e	e	NOUN
ajird-1300	126	64	,	,	PUNCT
ajird-1300	126	65	serri	serri	NOUN
ajird-1300	126	66	o	o	PROPN
ajird-1300	126	67	,	,	PUNCT
ajird-1300	126	68	legg	legg	PROPN
ajird-1300	126	69	k	k	PROPN
ajird-1300	126	70	,	,	PUNCT
ajird-1300	126	71	murphy	murphy	PROPN
ajird-1300	126	72	lj	lj	PROPN
ajird-1300	126	73	,	,	PUNCT
ajird-1300	126	74	ezzat	ezzat	PROPN
ajird-1300	126	75	s	s	PART
ajird-1300	126	76	/canadian	/canadian	NOUN
ajird-1300	126	77	guidelines	guideline	NOUN
ajird-1300	126	78	for	for	ADP
ajird-1300	126	79	the	the	DET
ajird-1300	126	80	management	management	NOUN
ajird-1300	126	81	of	of	ADP
ajird-1300	126	82	adult	adult	NOUN
ajird-1300	126	83	growth	growth	NOUN
ajird-1300	126	84	hormone	hormone	NOUN
ajird-1300	126	85	deficiency.//	deficiency.//	PROPN
ajird-1300	126	86	clin	clin	PROPN
ajird-1300	126	87	invest	invest	VERB
ajird-1300	126	88	med	med	PROPN
ajird-1300	126	89	.	.	PUNCT
ajird-1300	126	90	2006	2006	NUM
ajird-1300	126	91	apr;29(2):83	apr;29(2):83	ADV
ajird-1300	126	92	-	-	SYM
ajird-1300	126	93	90	90	NUM
ajird-1300	126	94	.	.	PUNCT